Medical screening in dental settings by Friman, Göran
From the DEPARTMENT OF DENTAL MEDICINE 
Karolinska Institutet, Stockholm, Sweden 
MEDICAL SCREENING IN DENTAL 
SETTINGS 
Göran Friman 
 
Stockholm 2017 
 
 All previously published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet. 
© Göran Friman, 2017 
ISBN 978-91-7676-484-8 
Printed by Eprint AB 2017   
  
Medical screening in dental settings 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
By 
Göran Friman 
Principal Supervisor: 
DDS, PhD, Associate professor Inger Wårdh 
Karolinska Institutet 
Department of Dental Medicine 
Division of Gerodontics and Academic Centre of 
Geriatric Dentistry, ACT 
 
Co-supervisor(s): 
DDS, PhD Margareta Hultin 
Karolinska Institutet 
Department of Dental Medicine 
Division of Periodontology 
 
Professor Gunnar Nilsson 
Karolinska Institutet 
Department of Neurobiology, Care Sciences and 
Society 
Division of Family Medicine 
Opponent: 
Professor Tiril Willumsen 
University of Oslo  
Faculty of Dentistry 
Institute of Clinical Dentistry 
  
Examination Board: 
Professor Jan Östergren 
Karolinska Institutet 
Department of Medicine K2 
 
RN, PhD, Associate professor Maja Söderbäck 
Mälardalen University 
School of health, Care and Social welfare 
 
RDH, PhD, Associate professor Annsofi 
Johannsen 
Karolinska Institutet 
Department of Dental Medicine 
Division of Periodontology and Dental Hygiene 
 
  
  
To Maria 
 
 
 
  
  
 
 
 
 
 
 
Amore, Heidi Fosli 2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Front cover 
The internationally renown, award-winning Norwegian artist and my dear friend Heidi Fosli, 
acclaimed for her revolution of impressionism, read my articles. With its content and our 
friendship as inspiration, I asked Heidi to create a work of art for me. 
This piece of art, like all her work, was painted intuitively out of her sentiments, which she 
described in words as: life, death, disease, research results, prevention, future window, light 
and discovery. 
Heidi named it Discovery, 2016 and it is shown here on the thesis front cover. Thank you, 
Heidi! 
ABSTRACT 
Background 
Findings have shown medical screening in dental settings to be cost-effective by achieving 
both financial savings and health benefits. The general purpose of this thesis was to study the 
possibility of early identification of individuals with undiagnosed diseases in a cooperative 
effort between dentistry and healthcare. 
The aims were to identify patients in a dental setting at risk of having or developing high 
blood pressure or high plasma glucose, and to investigate possible associations between these 
conditions and periodontal status, followed by a seven-year term study of the correlation 
between initial screening results and the progression of health. Further on, the patients’ 
experiences as well as the attitudes of some relevant authorities and organizations were 
explored. 
Methods 
A total of 170 dental patients were consecutively included at their regular annual check-up. 
Data on age, weight, height, amount and use of tobacco and pharmacological treatments for 
cardiovascular disease and diabetes were collected through self-reported information in a 
written health declaration, along with data on systolic and diastolic blood pressure, and 
plasma glucose. Clinical and radiographic examinations revealed data about periodontal 
status by probing periodontal pockets and measuring marginal alveolar bone loss by means of 
x-rays. Patients who exceeded normal diastolic blood pressure and plasma glucose values 
were referred to healthcare for diagnosis and care. 
With a strategic sampling of patients, authorities and organizations, 17 patients and 13 
representatives for authorities and organizations were interviewed. The interviews were 
recorded and transcribed. The transcriptions were coded and categorized in a manifest 
analysis, followed by a latent, interpretive analysis. 
The initial screening’s 170 participants were then asked to take part in a seven-year follow-up 
study. Data were collected through a repeated written health declaration. 
Results 
Thirty-nine patients exhibiting risk values were provided referrals and 24 (14.1%) of the 170 
participants required additional care. The correlation between dentistry and health care 
concerning blood pressure was 64.5% (p<0.001), while the correlation was 40.0% (p<0.001) 
concerning plasma glucose. Among middle-aged men and elderly subjects, the data showed a 
significant correlation between marginal alveolar bone loss and high systolic blood pressure 
(p<0.001). 
  
  
The manifest analysis of the patients’ experience resulted in three categories: Positive attitude 
to screening but dental professionals need to have specific knowledge of medical screening; 
Dental care provides continuity but is not a neutral environment; and Feedback on the 
medical screening results and desired cooperation between dental and healthcare services.  
The manifest analysis of the approached authorities and organizations resulted in four 
categories: Medical screening ought to be established in the society; Dentistry must have 
relevant competence to perform medical screening; Dentistry is not the only context where 
medical screening could be performed; and Medical screening requires cooperation between 
dentistry and healthcare. 
The latent analysis of the patients’ experiences pointed out the importance of the patient 
feeling that the procedure is carried out properly and safely, and identified requests for clear 
feedback concerning the results of the screening. The representatives for the authorities and 
organizations were positive to, but uncertain about, the concept of medical screening in dental 
settings. They requested further scientific knowledge and guidelines as well as long-term 
follow-up of medical screening. 
The follow-up study consisted of 151 participants. The risk for pharmacological treatments 
for hypertension after seven years for those not receiving pharmacological treatment at the 
initial screening was 54.2 times greater (p<0.0001 CI 9.8-300.3) for those with a systolic 
blood pressure >160 mm Hg than for those with a systolic blood pressure <140 mm Hg. 
Regarding diabetes, it was not possible to do risk calculations due to the limited group sizes. 
The changes in treatment were not significant. 
Conclusions 
An opportunistic medical screening seems to identify at least one in ten patients with 
undiagnosed hypertension or incorrect pharmacological treatment, and risk patients referred 
by dentistry who are not considered to require further healthcare interventions may benefit 
from an annual screening. The results also emphasize the need for increased cooperation 
between dentistry and healthcare. 
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1 PROLOGUE 
Once upon a time Maria, my wife, best friend and colleague, 
said to me: 
- We have been worked in our own clinic in Filipstad, a small 
town in mid-Sweden, for nearly 20 years now. We see our 
patients once a year and we can follow how their oral heath 
develops, generally for the better, but also their general heath. 
When a patient tells me about, or I see signs of, deteriorating 
general health, I ask, ‘Have you seen a healthcare provider?’ 
Often, they answer ‘No!’  
“Why can’t we check their blood pressure (BP) and plasma 
glucose (PG) for example, when we do our annual check-up? 
That was how it all started (Figure 1)!   
At all of our patient appointments, we try to see the whole person, not just a mouth with a 
row of teeth – few or many. We ask them how they are doing. Usually they answer with 
something like “All right”, “I’m still standing” or “Could be worse”. When we then ask, 
“How are you for real?” we hear how things are for real. 
We, the dental nurses and two dentists working at our clinic, all share a view advanced by 
some ancient Greeks and shown by today’s research: there is a connection between oral 
health and general health. With that philosophy and knowledge, we started early with the 
routine of sending referrals to healthcare services when we had good reason to suspect local 
or general lesion outside our competence. Our patients preferred that we sent a referral 
instead of seeking care themselves. 
We decided to start a project, “Medical screening in dental settings”, and conduct 
opportunistic medical screening by registering BP and PG in combination with the usual 
dental, periodontal, mucosal data and general anamnesis at the annual check-up. But first 
we had to study the existing current scientific literature. 
We contacted Gunilla Nordenram, now associate professor emerita at the Department of 
Dental Medicine at Karolinska Institute, with whom we already collaborated in the area of 
gerodontics development. She agreed to supervise us in the early phases and then Inger 
Wårdh “inherited” us, as she was successor associate professor and accepted the main 
supervisor assignment. They were both enthusiastic but also cautioned us that the journey 
would be long and time-consuming. To support us, Margareta Hultin, specialist in 
periodontics, and Gunnar Nilsson, professor of family medicine, agreed to come in as co-
supervisors. 
Figure 1.  
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Concurrently with the literature studies, we hired medical staff who taught all of us at the 
clinic the practice and the theory behind screening and obtained necessary medical 
equipment. We wanted to have the right tools and the skills to be able to answer the 
patient’s questions. Furthermore, we informed the primary healthcare centres and the 
private doctor in the town and established cooperation with Dr. Nils Regnström, who took 
the primary responsibility for the follow-up of our general medical test results that indicated 
disease risk. Sadly, Nils Regnström passed away before he could review the analysed data. 
We thank him for the indispensable and insightful contributions he provided while he was 
with us. 
With the tireless and never-ending support of Maria and our three daughters, Sandra, Petra 
and Mikaela, I began my doctoral thesis journey.  
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2 THESIS SUMMARY 
Obesity is a growing health condition with following disorders and sequelae like diabetes 
and hypertension with their disease complications, which occur if not treated early in the 
disease progression. 
Opportunistic medical screening could be a possible approach for the early identification of 
individuals at risk. As individuals generally visit dental care more often than medical care, 
medical screening in dental settings could be a model for improving public health and 
reducing individual suffering and costs to society. Dental care as a context may be 
particularly suited, as current research shows associations between oral and general 
diseases. 
By performing a screening and documenting the findings, the effects of such activity could 
be determined. How patients experience such a new feature at a regular dental examination 
could also be valuable to document, as well as the authorities’ and organizations’ attitudes 
to such activities. Further on, conducting a follow-up after some years to provide guidance 
about the possible long-term effect of opportunistic medical screening in dental settings 
would also be interesting. 
With these skills, an implementation could more easily be achieved. This is what this thesis 
is about. 
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3 INTRODUCTION 
Setting and epidemiology 
For this thesis, data was collected from a population in a small industrial community in a 
sparsely populated area in mid-Sweden with about 10,600 residents (1). Data concerning 
medication for high BP and diabetes mellitus (DM) and frequency of visits to dental care was 
taken from a 2012 study conducted by Värmland County through questionnaires with self-
reported information. The results from the municipality concerned for the age group 60-70 
years showed that 29.4% medicated for high BP and 17.1 % for DM, as compared with 
29.2% medicating for high BP and 12.5% for DM in the whole county (2). 
These figures can be compared with Swedish national data collected in 2012 for the 45-64 
age group: 22% (CI 20.8-23.7) medicated for high BP and 6% (CI 5.1-6.7) for DM, and for 
the 65-84 age group: 55% (CI 53.6-57.3) medicated for high BP and 14% (CI 12.3-15.0) for 
DM (3). 
These data indicate that the population in the municipality concerned had more identified and 
medicating diabetics and less identified and medicating individuals with high BP than 
elsewhere in Sweden.  
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4 BACKGROUND 
The objective of this thesis was to identify patients in an ordinary real-world dental setting at 
risk of already having or developing high BP or high PG, investigate possible associations 
between these conditions and periodontal status and explore the correlation between the 
results registered by medical screening in dental settings and follow-up assessments 
concerning the need for medical treatment and/or lifestyle changes performed by medical 
staff.  
Another objective was to form a basis for routines before the implementation of opportunistic 
medical screening activity in dental settings. This aim was meant to be achieved by literature 
studies, clinical testing and my own research on the concept. 
 
4.1 PERIODONTITIS 
General features and condition 
In the oral cavity, teeth are attached by the periodontium to the 
bone tissue of the jaws. The periodontium comprises gingiva, 
periodontal ligament, root cementum and alveolar bone 
(Figure 2). The functions of the periodontium are also to 
maintain the integrity of  the mucosal barrier and to protect the 
underlying tissues, blood vessels and circulatory system (4). 
The tooth perforates the mucosal barrier, and when the free 
gingiva that surrounds the tooth is healthy it closes tightly 
around the tooth to seals and protects against intrusion. 
Pathogenesis 
Bacteria in dental plaque is an important 
driving factor in the inflammatory response 
of the periodontal tissues. This host-mediated 
immunological defence can lead to 
epithelium ulceration and disruption, and 
ultimately an irreversible destruction of the 
periodontium (Figure 3). 
The diagnosis of current or historical 
periodontal disease (PD) is made by clinical 
examination, and determined by bleeding 
on probing of the gingival and periodontal 
pocket, using a probe equipped with a    
Figure 2.  
Figure 3.  
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0.5-mm ball tip. This leads to clinical assessment of inflammation in the tissue, registering of 
probing depth and clinical attachment loss. Periodontal status can also be historically assessed 
by a radiographic examination measuring the marginal alveolar bone loss on bitewing 
radiographs (4).  
Epidemiology 
Several index systems for the evaluation of these parameters have been developed, which 
makes it difficult to compare the prevalence of periodontitis among the different studies. In 
Sweden, though, epidemiological data from 1973 to 2003 showed an unchanged 6-8% 
prevalence of advanced periodontitis and an increase of periodontal healthy individuals from 
8 to 44%. As explanation for the improved periodontal health, the authors refer to better oral 
hygiene (5). 
Chronic periodontitis is the most frequent form of periodontitis. It progresses at a very slow 
rate and is usually painless until the disease develops into severe periodontitis (4). 
Periodontitis is often referred to as a “silent disease”, which means that the patient is more or 
less unaware of or is neglecting the disease. 
 
4.2 PERI-IMPLATITIS 
General features and condition 
Implant installations and jawbone-anchored dental 
replacements are an increasingly used therapy when 
masticatory function or aesthetics are adversely affected due to 
tooth loss. 
At approximately six weeks’ post-installation, the surrounding 
bone of the implant forms a stable hard tissue with close 
proximity to the implant. This “bone-implant contact” is called 
osseointegration (Figure 4). 
 Pathogenesis 
Peri-implant diseases consist of two different states: peri-implant mucositis with bleeding on 
probing of the mucosa and no bone loss, and peri-implantitis with mucositis and loss of 
supporting bone (Figure 5). For conditions presenting probing depths of 5 mm or more and 
suppuration, peri-implantitis can usually be diagnosed (6).       
Figure 4.  
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Epidemiology  
As for periodontics, there are 
several index systems for 
evaluating and determining the 
prevalence of peri-implant 
mucositis and peri-implantitis. 
However, it is reasonable to assess 
that peri-implant mucositis is 
present in 40-48% of the implant 
patients and the proportion of 
patients with peri-implantitis is 
registered in 30-55% (4). 
 
 
 
4.3 DIABETES 
General features and condition 
Diabetes mellitus is a term for a chronic disorder that 
arises when the pancreas (Figure 6) cannot produce a 
sufficient amount of insulin or the human cells cannot 
use insulin. The condition is diagnosed and followed 
up by registering the instantaneous level of PG or the 
level of HbA1c, which reflects an average level of PG 
over the past two to three months. Haemoglobin, Hb, 
is a blood pigment that carries oxygen and HbA1c is a form of haemoglobin that is bound 
to glucose. The hormone insulin is required to transport the glucose from the blood stream 
into human cells, where it is used as energy (7).  
There are three main types of diabetes and triggering risk factors (7): 
 Type 1 diabetes – genetic and ethnic disposition, infections and other environmental 
influences  
 Type 2 diabetes – genetic and ethnic disposition, obesity, physical inactivity, poor 
nutrition, past history of gestational diabetes, aging 
 Gestational diabetes – appears during pregnancy 
  
Figure 5.  
Figure 6. 
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Pathogenesis 
Type 1 diabetes 
An autoimmune reaction is behind type 1 diabetes. The human immune system attacks the 
insulin-producing beta cells (β-cells) in the tissue called the islets of Langerhans in the 
pancreas. The onset often occurs suddenly and in children or young adults. Common 
symptoms are abnormal thirst, constant hunger and a dry mouth combined with frequent 
urination and extreme tiredness (7).  
Type 2 diabetes 
The most common type of DM is type 2 diabetes. The onset is insidious usually in adults, but 
nowadays increasingly seen in adolescents and children. The beta cells can still produce 
insulin, but human cells that need glucose become resistant and so the human-produced 
insulin is insufficient. Common symptoms are about the same as in type 1: abnormal thirst, 
constant hunger and a dry mouth combined with frequent urination and extreme tiredness. 
The insidious development of type 2 starts with conditions named impaired glucose tolerance 
(IGT) or impaired fasting glucose, which are preliminary stages of diabetes, sometimes called 
“prediabetes” (7). 
In addition to the already mentioned risk factors for type 2 diabetes, recent research suggests 
that sleep disturbances can be added to the list (8). 
Gestational diabetes 
Hyperglycaemia, an elevated level of plasma glucose that occurs and is first detected at any 
time during a pregnancy, is categorized as gestational diabetes mellitus (7). 
Diabetes complications 
If there is a lack of insulin or a deficiency in cell uptake of PG, glucose remains circulating 
in the blood stream. High levels of glucose lead to vascular damage in the capillaries and 
blood vessels, which causes CVD and organ lesions in the kidneys, nerve tissues and 
eyegrounds, among other health complications. People with 
uncontrolled diabetes or poor glucose control are also at increased 
risk of developing infections and have an increased risk of 
inflammation (7). 
The level of PG is so important as one of the main causes of CVD 
that an oral glucose tolerance test, performed before hospital 
discharge after acute myocardial infarction, can disclose an unidentified glucose abnormality 
and thereby the risk for a future major cardiovascular event (9). A hyperglycaemic state also 
Figure 7. 
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results in various pro-inflammatory effects (Figure 7) which affects the inflammatory 
response of the whole body’s organs and tissues (10).  
Epidemiology 
Most diabetics live in low- and middle-income countries. According to a global study 382 
million people worldwide were estimated to have diabetes in 2013 and the forecast for 2035 
is 592 million in the 20-79 age group. In Sweden, the percentage of diabetics in 2013 was 
6.4% and estimated to rise to 6.6% by 2035 (11). The most prevalent form of DM is type 2, 
and its prevalence continues to increase. Up to 91% of adults with DM in high-income 
countries have type 2 diabetes (7).  
In a 2001-2004 study using data from Stockholm, Sweden, mean age 74.0, the prevalence for 
diabetes was 9.5% (12). A 2009 study of a population aged 65–74 in northern Sweden 
showed a prevalence of 12.0% for diabetes (13).  
The pharmacological costs for treating solely DM in Sweden account for 4% of the total costs 
of the disease. The other 96% of costs are attributed to complications and visits to healthcare 
facilities (14). Globally, 12% of the healthcare expenditure was spent on DM and related 
complications (7). 
 
4.4 HYPERTENSION 
General features and conditions 
Blood pressure is usually recorded with a BP cuff with a mercury manometer or instrument 
which records the corresponding value. There are two pressures that are registered, one high 
and one low. The higher pressure, the systolic BP, is when the heart beats and pumps the 
blood around. The lower one, the diastolic BP, is when the heart relaxes between beats. When 
the BP is raised, with systolic BP exceeding 140 or diastolic BP exceeding 90 mm Hg, the 
condition is termed hypertension (HT) and antihypertensive pharmacological treatment is 
indicated independent of level of total cardiovascular risk (15).  
A raised BP increases the risk of stroke, heart enlargement, incidence of other CVDs and 
finally death. The risk is based not only on BP, but increases in combination with other 
factors such as genetic disposition, diabetes, raised blood lipids, obesity, poverty, low 
educational status, advancing age, male gender and psychological factors and behavioural 
risk factors as tobacco use, physical inactivity, sleeping disorders, unhealthy diets and 
harmful use of alcohol. The higher the BP and the more risk factors, the greater the risk (16). 
In addition to the already mentioned risk factors for hypertension and CVD, recent research 
suggests that sleep disturbance can be added to the list (8). 
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Pathogenesis 
HT is an age-related, slow-developing and leading risk factor for premature death. The 
diastolic and systolic BP have different meanings as risk indicators at different ages. The 
diastolic BP is the best risk indicator for those under 50 years of age, especially women. 
Between ages 50-65, the two pressures show equal significance, but over age 65, the systolic 
BP is the best risk indicator for cardiovascular events. Most modern risk charts are 
nevertheless based on the systolic pressure, combined with age, smoking, blood lipids and 
diabetes (16). When HT presents due to peripheral arterial disease, vascular stiffness or 
ambulatory pulse pressure, which is defined as the difference between systolic and diastolic 
BP, can predict cardiovascular events (17), especially in patients with type 2 diabetes (18). 
HT is one cause of atherosclerosis, which in 
return affects BP. Atherosclerosis is a complex 
pathological process, an inflammatory process 
affecting medium- and large-sized blood vessels, 
and develops over many years. Fatty material 
and cholesterol are deposited inside the lumen of 
arteries lining the endothelium (Figure 8). This 
occurs when the inner surface of the vessel is 
exposed to raised levels of low-density 
lipoprotein cholesterol (LDL cholesterol) or 
other substances like circulating inflammatory mediators and free radicals (19). Through this 
inflammatory initiation and process, an atheromatous plaque is formed (16). 
These deposits, plaques, cause the inner surface of the blood vessels to become more narrow 
and less elastic, making it harder for blood to flow through. Eventually, the plaque can 
rupture, triggering the formation of a blood clot (16).  
Epidemiology 
Hypertension is a major risk factor for public health due to its association with cardiovascular 
disease (CVD) and kidney events. HT affects more than one-third of adults aged 25 and older 
worldwide according to the World Health Organization (WHO) and is responsible for 9.4 
million of the deaths from CVD each year. It is estimated that there will be 23 million 
cardiovascular deaths worldwide due to HT by the year 2030 (16). 
The Swedish prevalence in the beginning of the early 2000s of HT, mean age 74.0 years, was 
74.9%, and 41.6% of the population medicated (12). The 2009 study of a population aged 
65–74 in northern Sweden, showed a 71.9% prevalence for HT and 44.9% of the study 
population used pharmacological treatment with antihypertensive drugs (13).  
 
Figure 8.  
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4.5 UNIDENTIFIED DIABETES AND HYPERTENSION 
Diabetes 
In 2015, 46.5% of all adult diabetics (20-79 years) worldwide were undiagnosed and unaware 
of their disease. Yet these figures vary by region, with 39.3% in Europe, 29.9% in North 
America and the Caribbean and 66.7% in Africa. Most of these cases involved type 2 
diabetes and individuals living in low- and middle-income countries (7). 
Untreated and unknown IGT involves a high risk of progressing to type 2 diabetes later in life 
and 6.7% of all adults worldwide are estimated to have IGT. Half of these are under the age 
of 50 and if the condition progresses to diabetes, the link to the development of CVD is 
significant (7). In 2015, the International Diabetes Federation estimated that, worldwide, one 
in eleven adults aged 20-79 has diabetes and one in two adults with diabetes is undiagnosed 
(7). 
A free medical screening for non-hospitalized subjects, provided at the main entrance of a 
hospital in Israel and supervised by healthcare, revealed that among subjects without known 
DM, 14.3% were at risk of prediabetes and 1.6% at risk of diabetes (20). 
Hypertension 
Undetected and uncontrolled hypertension increases the cardiovascular risk of stroke and 
additional CVD. The prevalence of HT differs globally depending on the socio-economic 
conditions. In low-, lower-middle- and upper-middle-income countries, the prevalence among 
adults is around 40% and in high-income countries around 35% for both genders (21). 
The medical screening of non-hospitalized subjects, 
mentioned above, revealed that among subjects without 
known hypertension, 9.6% had blood pressure ≥140/90 
(20). In a 2005 study of urban Chinese adults aged 20-79, 
37.3% of the participants with HT were undiagnosed. The 
article was summarized by the conclusion: “the prevalence 
of pre- and undiagnosed-hypertension was ~ 50% among 
urban Chinese adults. Abdominal obesity, low socio-
economic status, alcohol drinking, physical inactivity and 
type 2 DM may be indicators for pre- and undiagnosed-
hypertension” (22). 
 
Figure 9.  
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4.6 ASSOCIATIONS’ BETWEEN ORAL HEALTH AND GENERAL HEALTH 
The epidemiological associations of 
PD and CVD have been recognized 
for just over three decades now and 
the association with DM has been 
acknowledged for over a century (23). 
In 2012, the scientific consensus was 
that PD exhibited associations with 
multiple systemic conditions, but 
there was a lack of knowledge about 
their nature and whether there were 
causal links. Then, current conditions 
and diseases were (Figure 10): DM, 
CVD, osteoporosis, preterm low-
birthweight babies, respiratory 
diseases and rheumatoid arthritis (24). 
Added to this list are those sequelae which can be indirectly caused by hyperglycaemia and 
diabetes, for example kidney disease (25). Oral bacteria have also been shown to contribute 
to the development of the pathology of Alzheimer’s disease (26). 
Apart from the already mentioned systemic effects of DM, an increased local PG level in the 
periodontal tissues provides an increased accumulation of end products of glucose 
metabolism, which leads to increased interaction between leukocytes and endothelial cells 
and changes in leukocyte functions. The increased levels of pro-inflammatory cytokines in 
periodontal tissues also stimulate tissue degradation (27).  
Epidemiological and biological data indicate that periodontitis, in turn, can affect diabetes 
through adverse effects of PD on glycaemic control, diabetic complications, and the 
development of type 2, and possibly gestational diabetes (28). More studies are needed to 
explain and clarify the two-way relationship between DM and PD. 
Possible associations between PD and CVD, such as atherosclerotic lesions, are presented 
in a current literature review (29). PD increases the risk for CVD by increasing the levels of 
pro-inflammatory cytokines and adhesion molecules in plasma and thrombotic markers like 
fibrinogen, which in combination with impaired endothelial function may cause the 
development of atherosclerotic lesions. The inverse there is that periodontal treatment 
reduces the risk of CVD by decreasing the plasma levels of inflammatory markers and 
improves the endothelial function (29). 
Figure 10.  
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Metabolic syndrome, as defined by WHO in 1998, is a condition in which a compilation of 
factors including dysglycaemia, visceral obesity, atherogenic dyslipidaemia (elevated 
triglycerides and low levels of high-density lipoprotein, HDL) and hypertension leads to an 
increased risk of developing CVD and DM (30). Increased understanding of the 
associations with PD could promote inter-professional cooperation and practice (31). 
Oral microbiome  
All environmentally exposed surfaces of the human body – skin and mucous membranes – 
have their different resident microbiota. The microbiota is the ecological community of 
commensal, symbiotic and pathogenic microorganisms inhabiting the human body in health 
and disease. Humans have a dynamic and intimate relationship with these microorganisms 
and a majority contribute to the health of the host. 
However, “Periodontal disease is a consequence of a breakdown in the normally homeostatic 
balance between the commensal microbiota and the immune and inflammatory systems of the 
tissues. In this regard, periodontal infections and the response to them represent an excellent, 
accessible, and tractable system to understand the underlying principles of a wide range of 
inflammatory diseases of humans characterized by a dysbiotic commensal microbiome” (4).  
This is of major importance to the host-mediated immunological inflammatory response that 
leads to periodontal epithelium ulceration and disruption, and opens the gates for intrusion 
and accessibility to the bloodstream (4).  
A recent review article (2016) presents growing evidence showing associations between the 
oral microbiome and oral and non-oral conditions/diseases including, in addition to those 
already mentioned, oral cancer, gastrointestinal and pancreatic cancer (32).    
Diet-associations between oral health and general health 
The expression “the way to a man’s heart is through his stomach” nowadays probably can 
apply to both genders, and diet must pass the mouth first. A current euphemism could then be 
“the way to human health is through the mouth”. 
This statement finds support in the fact that the Mediterranean diet has an immune protective 
effect against atherosclerosis and other chronic low-grade inflammatory diseases like visceral 
obesity, the metabolic syndrome and type 2 diabetes, neurodegenerative diseases and cancer, 
which is considered to be a chronic inflammation (33, 34). 
Another sort of association is in the meaning of the oral and general tissue response 
concerning similar effects of different diets. A diet low in carbohydrates, rich in omega-3 
fatty acids, vitamins C and D, antioxidants and fibre, without any changes in oral hygiene, 
significantly reduces gingival and periodontal inflammation. This conclusion was presented 
in an admittedly small limited pilot study, published in 2017, but provides incentive for future 
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studies in the field, given that this diet has a similar effect on other general inflammatory 
diseases (35). 
# 
Common sense has long held that the mouth is part of the body. Science verifies this. The next 
step is therefore increased interprofessional cooperation between dental care and medical 
services for improved public health. 
 
4.7 ATTENDANCE RATE 
A questionnaire study with self-reported information conducted by the county of Värmland in 
2012 revealed that the attendance rate of visits to dental care during a period of two years in 
the county of Värmland was 94.3% for the 60-70 age group and the results from the 
municipality concerned was 93.2% (2) in comparison with 72.7% of the adult population 
nationwide in Sweden from the years 2010 to 2011 (36). 
These data indicate that the 60-70 age group in the municipality concerned visited dental care 
more frequently than the adult population in Sweden and that dentistry has a high degree of 
coverage in the age group. 
In the United States (US), 24.1% of adults over the age of 18 did not have contact with a 
general healthcare provider in 2008, but 23.1% of those did see a dentist during that year 
(37).  
 
4.8 PATIENT’S AWARENESS OF BLOOD PRESSURE AND PLASMA GLUCOS  
As part of the clinic’s internal quality development, a study was conducted in the previously 
mentioned sparsely populated area in mid-Sweden to examine how well ordinary people 
knew their vital signs such as BP and PG. At the annual check-up, 257 patients were asked 
about their awareness of vital signs. Information about their health history was also collected 
through a self-administered written health declaration. 
The mean age was 60.7 years with a range of 21-92 years. The participants were 43.6% men 
and 56.4% women. The awareness of one’s own BP was more common, 54.5%, mean age 
64.8, than the awareness of the PG 33.1%, mean age 64.2. For more details, see Tables 1 – 3.  
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Table 1. Patient’s awareness of vital signs and health history; total and according to gender 
 Total yes Men yes Women yes 
 Variables N=257 n=112 n=145 
 n % n % n % 
 Awareness of blood pressure 140 54.5 59 52.7 81 55.9 
 Having hypertension 88 34.2 33 29.5 55 37.9 
 Awareness of plasma glucose 85 33.1 38 33.9 47 32.4 
 Having diabetes mellitus 13 5.1 8 7.1 5 3.4 
 
Opportunistic medical screening is most valuable for those who do not know their vital signs, 
so a descriptive analysis of unawareness was carried out among those who had not been 
previously diagnosed. 
Table 2. Not medicating patient’s unawareness of blood pressure; total, according to gender 
and mean age 
 Variables Total Men Women 
 Not medicating BP N=169 n=79 n=90 
 n % age/year n % age/year n % age/year 
 Unawareness of BP 100 59.2 54.6 45 57.0 53.8 55 61.1 55.2 
 Standard deviation, SD    15.334   14.094   16.378 
 
Table 3. Not medicating patient’s unawareness of plasma glucose, total, according to gender 
and mean age 
 Variables Total Men Women 
 Not medicating DM N=244 n=104 n=140 
 n % age/year n % age/year n % age/year 
 Unawareness of PG 169 69.3 58.8 71 68.3 57.0 98 70.0 60.2 
 Standard deviation, SD    15.639   14.424   16.407 
 
This internal quality study revealed that a little fewer than two-thirds of those without 
diagnosed hypertension were unaware of their blood pressure and more than two-thirds of 
those without diagnosed DM were unaware of their PG. 
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4.9 SCREENING OF SALIVARY MARKERS AND FOR OSTEOPOROSIS 
In the study, which constituted the basis for this thesis, an invasive 
method was used to screen for the risk of high PG levels (38). The PG 
was measured by a capillary blood sample.  
Saliva from the salivary glands (Figure 11) is a complex liquid containing 
an entire library of endogenous substances. Studies have shown that the 
human salivary proteome contains certain proteins which can be linked 
to prediabetes and type 2 diabetes. One of these biomarkers is the pro-
inflammatory alpha 2-macroglobulin (A2MG) (39).  
A non-invasive method for the detection of prediabetes and diabetes can increase the patients’ 
likelihood of complying with and facilitating the sampling. In accordance with the 
bidirectional causal connection between diabetes and periodontitis (10), and as the salivary 
A2MG has a significant correlation with HbA1c, fasting glucose and periodontal status, this 
biomarker can provide an opportunity to use a non-invasive test for diabetes screening and 
provide a biological indicator for diabetes control from a saliva sample (40).  
With an increasing elderly population, the incidence and prevalence of cancers will be 
expected to increase (41). Salivary biomarkers have proven to be a promising diagnostic and 
prognostic tool for the detection of several types of cancers such as breast cancer, lung 
cancer, ovarian cancer, pancreatic cancer and, not least, for oral squamous cell carcinoma, 
which is the most common oral cancer (42). Since the human papillomavirus (HPV) is behind 
a large number of oral cancers, screening of salivary biomarkers can be considered for 
additional groups other than the elderly (43). Further research is still needed regarding 
salivary biomarkers, but they are likely to play a significant future role in medical screening 
in dental settings. 
Dental professionals can also play a role in screening for osteoporosis, a major public health 
problem especially in post-menopausal women, by using a basic radiography measurement 
technique to determine the thickness and morphological changes of mandibular inferior 
cortical bone (44, 45). 
 
4.10 MEDICAL SCREENING IN GENERAL 
In a Cochrane review article, general health checks were evaluated and the authors found 
that such activity did not reduce morbidity or mortality. Nevertheless, they recommended 
that screening for specifically targeted tests, such as for cardiovascular risk factors, chronic 
obstructive pulmonary disease, diabetes or kidney disease, should be studied further in the 
future (46). The Swedish Agency for Health Technology Assessment and Assessment of 
Figure 11.  
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Social Services (SBU) has commented on the Cochrane review and studied other literature, 
which shows a positive effect of screening for specifically targeted disease like CVD (47). 
In 2009, an English NHS Health Check programme was introduced in adults aged 40–75 
with the objective of early identification by healthcare providers of non-communicable 
diseases like HT and DM (48). A retrospective evaluation of the programme in a multi-
ethnic population was published in 2015. Over a five-year period, 10.8% of the individuals 
were diagnosed as at high risk of unidentified CVD and 5.7% of the individuals were 
diagnosed with unidentified type 2 diabetes (49). 
Ethical considerations 
Ethical problems concerning screening is a controversial issue, not least in genetic carrier 
screening (50). But the impact of diabetes screening seems not to have a negative influence 
on patients’ perception of health-related quality of life regardless of whether the screening 
results in a diagnosis or not (51). Under what circumstances should the screening be 
performed? In 1996, SBU proposed principles for when screening is beneficial (52): 
 What impact does the disease have? 
 Is the diagnosis method good enough? 
 Is there access to effective treatment? 
 Are the costs in proportion to the impact? 
Selection for screening 
If the above principles are met, there may be other guidelines in the selection of risk 
patients. When selecting individuals for DM screening, the risk factors can be appropriate 
criteria for selection (7): 
 Genetic and ethnic disposition  
 Obesity 
 Physical inactivity 
 Poor nutrition 
 Past history of gestational diabetes 
 Advancing age 
HT is also an age-related disease and the age-related increase in systolic blood pressure is 
linear between 30-40 years of age and slightly steeper for women than for men (53). An 
opportunistic medical screening of those who attended a daily outpatient clinic for HT was 
conducted in India and involved adults aged 30 and above. This study showed that the 
frequency of undiagnosed HT and prehypertension in an opportunistic screening in rural 
areas was 17.9% and 37.7%, respectively. Obesity was the most modifiable risk factor. A 
majority of the undiagnosed HT was detected in the 30-49 age group and in males (54). 
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The risk factors for HT mentioned in the “Global Atlas on Cardiovascular Disease Prevention 
and Control” can form criteria to consider in a screening selection for HT (16). 
 Genetic disposition 
 Obesity 
 Diabetes mellitus 
 Raised blood lipids 
 Poverty 
 Low educational status 
 Advancing age 
 Male gender 
 Psychological factors 
 Tobacco use 
 Physical inactivity 
 Sleeping disorders 
 Unhealthy diets 
 Harmful use of alcohol  
In the selection for screening and identifying undiagnosed DM and HT, the sampling 
becomes quite similar. 
 
4.11 COOPERATION BETWEEN DENTAL AND MEDICAL CARE 
In Swedish county councils and regions, there is generally access to hospital dental care in 
connection with healthcare. With the objective of specifying the care activities, the field of 
“orofacial medicine” has developed and comprises the prevention, diagnosis and treatment of 
complex oral conditions related to systemic diseases and/or disabilities. Where those 
activities occur, natural collaboration between dental and healthcare exists. 
Historically, oral health and general health have been separated in legislation, education and 
service delivery. However, recent developments and new knowledge are forcing a shift to 
unite dentistry and medicine or at least increase and manifest an enhanced cooperation 
between primary care and general dental care (55). 
The role of education is important. In the early 2000s, a trend started in the US and dental 
hygienists, as prevention specialists, took an integral role in healthcare to detect the presence 
of general diseases, which resulted in educational requirements for medical screening (56). 
Healthcare has also reached an increased awareness of the need for education and knowledge 
in oral and dental core competencies, particularly when frail or chronically ill patients more 
often seek healthcare than dentistry (55). In Sweden, Uppdrags AB at Karlstad University has 
taken a nationally unique initiative and offers a course in oral and dental core competencies 
directed at nurses (www.kau.se). 
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In order to encourage healthcare to increase cooperation, the Swedish National Board of 
Health and Welfare recommended in 2015 that healthcare providers refer diabetics with an 
increased risk for impaired oral health to dental care. These National Guidelines for 
Diabetes Care promote increased cooperation (57). 
The Texas Administrative Code, US, RULE §108.8 “Records of the Dentist” stipulates that 
records must include documentation of “Vital signs, including but not limited to blood 
pressure and heart rate when applicable in accordance with §108.7 of this title”. Registration 
of BP is a regular routine when visiting dental settings! 
Dr. Lisa Simon, Harvard School of Dental Medicine, Boston US, finishes her article 
“Overcoming Historical Separation between Oral and General Health Care: Interprofessional 
Collaboration for Promoting Health Equity” with the Conclusion (55): 
“As awareness of inequality in access to oral health and its importance in overall health 
grows, dentists, physicians, and other health professionals have begun to take up the mantle 
of oral health integration. Such efforts can take the form of novel insurance structures, 
practice models, or other innovations. Above all, both dental and medical education will 
play critical roles in preparing future practitioners for these changes. Working and training 
together, trainees in medicine and dentistry can unify oral and general health care.” 
# 
Medical screening in dental settings can be a start for some and stimulus for others. 
 
4.12 MEDICAL SCREENING IN DENTAL SETTINGS 
Results from different sorts of medical screening in dental settings have been published since 
the mid-1990s (58).  However, US Professor Michael Glick’s 2002 article “Screening for 
traditional risk factors for cardiovascular disease. A review for oral health care providers” 
became somewhat of a starting point for publications of research related to medical screening 
in dental settings (59). In 2007, Dr. Sevek Engström published one of the first articles in 
Sweden about medical screening in dental settings (60). 
Since then, many articles have been published on this subject and medical screening seems to 
be supported by patients, dental hygienists, dentists, physicians and authorities and 
organizations (61, 62). Research which, among other data, is presented in these dissertation 
articles. 
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Selection for screening 
Should all dental patients be screened or just certain groups? First of all, previously listed 
general risk factors can form the basis for a selection in addition to oral health registrations 
and oral infections, specifically PD, active and historical. Historical PD can be seen as 
marginal alveolar bone loss on bitewing (63). Number of missing teeth can also serve as the 
basis due to an increased risk for cardiovascular events and all-cause mortality (64). 
In the implementation of the intraoral soft tissue screening, which is particularly important 
due to premalignant and malignant lesions, all oral mucosa is scanned (65). This screening 
also comprises the underside of the tongue and assesses the extent of sublingual varices, 
which recently has shown to have an association to HT (66).  
Levels for risk 
An elevation of systolic BP higher than 180 mm Hg or diastolic BP higher than 110 mm Hg 
is used by many dental clinicians in the US as a cut-off value for medical consultation and 
referral (67). But the maximum levels for risk is something determined by the cooperation 
partner, the healthcare provider, as dental care does not impose a general medical diagnosis. 
Working closely with healthcare is therefore a prerequisite for medical screening in dental 
settings. 
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5 AIMS OF THE THESIS 
General aims 
The general aim of this thesis was to increase cooperation between dental and medical care 
for early identification of individuals at risk for public health problems. 
Identifying patients in dental settings at risk of cardiovascular disease and diabetes 
(Study I) 
To identify patients in a dental setting at risk of already having or developing high blood 
pressure or high plasma glucose, investigate possible associations between these conditions 
and periodontal status, and explore the correlation between screening results and follow-up 
assessments concerning the need for medical treatment and/or lifestyle changes performed by 
medical staff. 
Patient experiences of medical screening performed by the dental services: A 
qualitative study (Study II) 
To explore how medical screening performed by the dental service was perceived from the 
patient perspective. 
Medical screening in dental settings: a qualitative study of the views of authorities 
and organizations (Study III) 
To describe the view of authorities and organizations in a Swedish context. 
Long-term follow-up of opportunistic medical screening for hypertension and 
diabetes within dentistry – a descriptive study (Study IV) 
To describe the distribution of diagnosis, pharmacological treatments and risk for 
hypertension and diabetes after seven years among patients opportunistically screened in a 
dental setting, and to analyse possible correlations over time between and among study 
outcome groups, gender and age. 
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6 MATERIAL AND METHODS 
6.1 STUDY I 
The study was approved by the local Ethical 
Committee in Uppsala, Sweden (file 2005:358) and 
was conducted in agreement with the terms of the 
Helsinki Declaration. 
Setting 
This study was performed in an everyday dental 
setting in a small town in mid-Sweden. At the time 
of the study, the clinic was responsible for treating 
about 1,450 adult patients with a mean age of 
approximately 57 years ranging from 20 to 
approximately 100 in age. All patients were 
enrolled in an individualized prophylactic care 
program and had appointments with the dental 
hygienist or prophylactic dental nurse on an 
individual basis. In addition to the prophylactic 
program, an annual full-mouth dental examination 
was generally performed on each patient by a 
dentist. For a flow chart of the medical screening, 
see Figure 12. 
Subject selection 
Two hundred seven consecutive regular patients   
≥ 40 years of age who had been recalled to their 
regular yearly check-up visits between March and October 2004 were invited to participate in 
the study. One hundred seventy patients agreed to participate. Upon receiving both verbal and 
written information about the study, all subjects included gave their informed consent for the 
study to be conducted. 
Study subjects were divided into two groups: 
1. Middle-aged: Patients ≥ 40 - ≤ 64 years of age during the year of data collection 
2. Elderly: Patients ≥ 65 years of age during the year of data collection 
  
Figure 12. Flow chart for medical 
screening in dental settings 
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Data collection 
Data were collected through a self-administered written health declaration made before the 
dental appointment: age, weight, height, type and amount of tobacco use and medication to 
treat CVD and DM. Body mass index (BMI) was calculated and defined as an individual's 
body weight divided by the square of his or her height. Overweight was defined as a BMI 
value above 30.0 for men and above 28.6 for women. 
Clinical examination 
After a five-minute rest in the dentist’s examination chair in the examining room, using 
digital BP registration data about both systolic and diastolic BP and pulse were collected (68). 
The BP and pulse rate were measured by using a wrist device, an automatic 
sphygmomanometer NAIS DIAGNOSTEC EW 3002 (Matsushita Electric Works, Germany). 
Plasma glucose was measured by means of a digital capillary blood sample, 3-3.5 μL using a 
medical device, a glucometer called Roche Accu-Chek Compact (Roche Diagnostics GmbH, 
Roche Diabetes Care, D-68298 Mannheim, Germany). The device was independently and 
objectively evaluated (69). 
Data collection for plasma glucose was not predominantly performed with fasting patients, 
which explains why the risk values determined rather than the diagnosis, were set by an 
experienced diabetes physician, Gunilla Hede of the Diabetes Centre, Karlstad Hospital, 
Sweden, with respect to the time lapsed since last consumed meal. For patients who had eaten 
during the past two hours, the value was set at 9.5 mmol/litre plasma and for those who not 
had eaten during the past two hours, the value was established at 8.0 mmol/litre plasma. For 
those fasting for the past eight hours, the cut-off value was set at 7.0 mmol/litre plasma (70). 
The cut-off values for diastolic BP was set at 90 mm Hg or more, except for diabetics in 
which case  the value was set at 85 mm Hg or more, generally 140 mm Hg or more for 
systolic BP. Patients who exceeded normal plasma glucose and diastolic BP values were 
referred to a medical doctor to have their values checked, possibly determine a diagnosis and 
initiate relevant therapy, or alternatively,  receive health promotion advice (23). 
All patients underwent clinical and radiographic examination performed by one of the clinic’s 
two experienced and calibrated dentists who followed a detailed written protocol for data 
collection. These dentists have enjoyed a lengthy professional relationship, both in 
educational and clinical contexts, and daily discuss how to best measure and interpret clinical 
findings. Other categories of staff had been undergoing training specific to the medical 
screening project. The number of teeth was counted. Clinical periodontal status was assessed 
by recording bleeding on probing (BOP) and by probing the pocket depth on five 
predetermined teeth in each patient, tooth numbers 16, 21, 24, 41, 44 (71) using a periodontal 
probe, LM 23-520B Si with a 0.5 mm ball diameter  tip (LM-Instruments Oy, Finland). 
 32 
 
Pocket depth was measured on six surfaces of each selected tooth (distobuccal, midbuccal, 
mesiobuccal, mesiolingual, midlingual, distolingual) and expressed in mm as the distance 
between the gingival margin and the base of the periodontal pocket. Recordings of pocket 
depth and BOP were made on four surfaces (distal, buccal, mesial and lingual) on each 
measured tooth, choosing the deepest site on the measured approximal surface. Only a pocket 
depth of ≥ 4 mm was recorded. 
Radiographic examination 
A radiographic examination of the periodontal status was undertaken on dentate patients and 
comprised of two or four bitewing x-rays using a standardized long-cone parallel technique, a 
routine examination as part of the yearly check-up visit (63). No bitewing x-rays were taken 
on patients with canine to canine small dentitions. 
The marginal alveolar bone loss on bitewing radiographs was measured on each patient using 
a digital slide calliper from the cemento-enamel-junction (CEJ) to the crest of the alveolar 
bone on the approximal surfaces of canines, premolars and molars. A Mattson binocular with 
two-fold magnification was used to measure the mm distance from the CEJ to the alveolar 
bone crest. The distance was recorded and rounded off to the nearest 0.1 mm (0.05 rounded 
up). Marginal alveolar bone loss represents the mean distance of each patient. Radiographic 
readings were made in a randomly selected order twice by two independent readers, authors 
Göran Friman and Margareta Hultin. If the CEJ on an approximal surface could not be 
detected, the CEJ on the opposite surface of the same tooth or the neighbouring tooth was 
used as reference. Missing data or which the CEJ or marginal bone crest was undetectable, 
were specified as percentages of the total number of measured surfaces. 
The agreement among examiners on radiographic readings was 90% and an analysis of the 
correspondence of the radiographic readings between the two examiners showed that the 
principal investigator (Göran Friman) measured the marginal bone loss to be a mean 0.1 mm 
less than the co-author and specialist in periodontology (Margareta Hultin). 
Quartiles of clinical and radiographic periodontal status 
To evaluate variations of BP and plasma glucose in patients with varying clinical and 
radiographic periodontal status, partitions into quartiles were set on marginal alveolar bone 
loss, as well as the number and mean depth of periodontal pockets bleeding with a total 
registered pocket depth of ≥ 4 mm. Table 4 shows the partition into quartiles. 
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Table 4. Quartiles of clinical and radiographic periodontal status 
Periodontal status 
Lower quartile 
(q1) 
Between lower and 
upper quartiles (q2) 
Upper quartile 
(q3) 
Number of pockets with depth ≥ 4 mm 0 > 0 - < 3 > 3 
Mean depth of pockets ≥ 4 mm 0 mm > 0 - < 4.5 mm > 4.5 mm 
Total mm of pocket depth ≥ 4 mm 0 mm > 0 - < 15 mm > 15 mm 
Marginal alveolar bone loss < 2 mm > 2 - < 3.4 mm > 3.4 mm 
 
Statistical Analysis 
Statistical analyses were performed using the SPSS statistical software (Release 18.0.0 SPSS 
Inc., Chicago, IL). Potential correlations between periodontal status and systolic/diastolic BP 
were analyzed using Student’s t-test, Spearman’s rank correlation and Chi-Square Tests with 
a p-value < 0.05 as significance level. 
 
6.2 STUDY II 
Ethics Statement 
The study is approved by the Regional ethical review board in Uppsala, Sweden, in 
accordance with the ethical standards and with the Helsinki Declaration of 1975, as revised in 
1983. The participants received both verbal and written information about the study and that 
they were not compensated for their time, all of them gave their written informed consent to 
participate sent by post. 
Procedure 
This qualitative study was based on individual interviews. It was conducted from March to 
May 2010 in a neutral venue not adjacent to the dental clinic in the town where the medical 
screening was performed. 
Twenty-eight patients who underwent medical screening at the dental clinic in addition to 
their dental examination were asked in a personal letter to participate in an individual 
interview. They were selected strategically to maximize the variety of data in terms of age, 
gender, professional background and results of the medical screening. 
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The interviews were conducted by one of the authors (Awara Kalkali) with open-ended 
questions from an interview guide focusing on two main areas: 
- How did the patients experience medical screening performed by dental 
professionals? 
- How do the patients perceive regular medical screening when integrated into the 
regular dental examination? 
The study process was inspired by Grounded Theory and the interviewees were asked to 
freely describe their experiences and opinions in conversational style (72). When necessary, 
the interviewer asked additional questions for clarification. The interviews lasted 
approximately 25-40 minutes and were audio taped and transcribed verbatim by another 
author (Ghazaleh Golestani). The transcription process was successively performed in the 
same order as the interviews. This procedure made it possible to check whether the interview 
guide or the interviews needed to be supplemented (72). After 17 interviews, the authors 
concluded that no new relevant information emerged, saturation was reached  and the data 
collection ended (72). 
Analysis 
As the study material did not have the prerequisites to entirely follow the Grounded Theory 
method, data was treated like a model similar to qualitative manifest and latent content 
analysis (73). The interview texts were read in their entirety by the authors and divided into 
groups of meaning-bearing units, codes. Similar codes were merged and then sorted into 
subcategories and categories. A comparison was made with the interview guide to see if the 
categories corresponded to the question areas. This represented the manifest level of analysis. 
Then the authors looked for a main category or a theme, the latent content analysis. 
The analysis was illustrated with quotations. The quotes presented in this article are typical of 
the views expressed by the interviewees and are used to exemplify the categories and theme. 
 
6.3 STUDY III 
Both quantitative and qualitative data were collected through a standardized questionnaire 
and subsequent interviews, but the study was mainly based on qualitative data (74). 
The study was approved by the Regional Ethical Review Board in Uppsala, Sweden, in 
accordance with the ethical standards and with the Helsinki Declaration of 1975, as revised 
in 1983. The participants received both verbal and written information about the study, they 
were not compensated for their time, and their participation was completely voluntary. 
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Study setting and population 
Through a purposive sampling (75), twenty Swedish authorities and organizations were 
contacted. The research team initially sought contact with the chairman, vice chairman or 
spokesperson. If none of these chief persons were able respond or were unavailable for an 
interview, another representative was requested as respondent. The research team 
considered the selection to be relevant to meet the purpose of the study. Thirteen 
participating authorities and organizations took part in the study and are described in   
Table 5. 
Table 5. Swedish authorities and organizations that took part in the study 
Authorities Organizations 
The Dental Board of the County Council of 
Värmland (Tandvårdsnämnden, Landstinget I 
Värmland) 
The Swedish Medical Association (Sveriges 
Läkarförbund) 
 
The Swedish Association of Dental Hygienists 
(Sveriges Tandhygienistförening) 
 
Swedish Dental Nursing Association (Svenska 
Tandsköterskeförbundet) 
 
The Swedish Association of Health Professionals 
(Vårdförbundet) 
 
The Uppsala Dental Service Organisation  
(Folktandvårdsföreningen, Folktandvårdens kansli 
Uppsala)  
  Praktikertjänst AB  
 
SKL - Swedish Association of Local Authorities 
and Regions (SKL –Sveriges kommuner och 
landsting) 
 
Swedish Diabetes Association (Svenska 
diabetesförbundet) 
 
The Swedish Stroke Association (STROKE-
Riksförbundet) 
 Faculty of Odontology at Malmö University 
 
Institute of Odontology, The Sahlgrenska Academy, 
Gothenburg 
 
Department of Dental Medicine, Karolinska 
Institute, Huddinge 
The Swedish names of authorities and organizations given in parentheses 
 
The selected authorities and organizations were contacted primarily by phone and those 
who gave consent to take part in the study got an email with further information and a 
questionnaire. 
Data collection 
Of the twenty purposive sampled Swedish authorities and organizations, there were seven 
dropouts. The reasons given for not participating were: not taken a position on the issue, not 
relevant instance, and not suitable as they work exclusively with issues regarding primary 
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and secondary education. One respondent did not reply. Thirteen Swedish authorities and 
organizations constituted the final study material. 
All respondents received a standardized questionnaire with eighteen questions concerning 
medical screening in dental settings to gain insight into the topic and prepare for an 
interview, as they were mainly supposed to express positive and negative opinions that 
characterized their authority or organization and not personal thoughts. The questionnaire 
design was first evaluated in a pilot study involving ten selected teachers at the Department 
of Dental Medicine, Karolinska Institutet, Huddinge. Using a traditional four-point Likert 
scale, respondents indicated to what degree a statement was consistent with their opinion by 
stating “Strongly disagree”, “Disagree”, “Agree” or “Strongly agree” (76). 
Qualitative data were collected through interviews by two trained calibrated interviewers 
with thirteen open-ended questions from an interview guide that addressed the relevant 
topics (Table 6). The guide was tested on a pilot person to optimize the questions and to get 
as comprehensive answers as possible. Each open-ended question had follow-up questions 
so as to, if possible, achieve saturation. The main portion of the interviews was conducted 
by phone and the rest during personal appointments at offices of the authorities and 
organizations from December 2012 to April 2013. 
Table 6. Interview guide  
Issues 
Territorial mentality 
Voluntariness of the patients, the dental care and the health care 
Patient’s perspective, integrity, confidentiality, availability, quality of life 
Quality of care and caring responsibilities 
Competence, the lowest level of care for risk assessment 
Education and qualifications 
Economics 
Legal affairs 
 
Each interview lasted approximately 40 minutes and was audio-recorded and transcribed 
verbatim. After thirteen interviews, the authors concluded that no new relevant information 
emerged, saturation was reached and the data collection ended (73). 
Data analysis 
The qualitative data were analyzed with qualitative manifest and latent content analysis 
(73). The interview texts were read in their entirety, discussed by the authors and divided 
into groups of meaning-bearing units, codes. Similar codes were merged and then sorted 
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into subcategories and categories. A comparison was made with the interview guide to see 
if the categories corresponded to the question areas. This represented the manifest level of 
analysis. The authors then looked for a main category or an underlying theme, the latent 
content analysis. The qualitative results were illustrated with quotations. The quotes 
presented were expressed by the interviewees and were used to exemplify the categories 
and theme. 
 
6.4 STUDY IV 
Design and setting 
The study had a descriptive design of a non-random sample of consecutively included 
patients, with a longitudinal perspective. 
The study was performed in an everyday private dental setting in a small town in mid-
Sweden in 2004 and 2011. All regular patients generally underwent an annual dental 
examination performed by a dentist. One hundred seventy patients agreed to participate in the 
initial screening project (Figure 13) (38). 
 
 
 
Figure 13. Flow chart for 
the initial screening and 
follow-up. Patients who 
exceeded normal PG and 
diastolic BP values were 
referred to medical 
healthcare to have their 
values checked (n1=39).  
Of those referred, 24 
received medical treatment 
(n2=24) and 15 did not 
(n3=15). One hundred 
thirty-one patients were 
deemed to not be at risk 
(n4=131). 
  
 38 
 
Data collection 
Initial screening 
Data were collected through a self-administered written health declaration made before a 
dental appointment: age, weight, height, type and amount of tobacco use, and 
pharmacological treatments of CVD and DM. Body mass index (BMI) was calculated and 
defined as an individual’s body weight divided by the square of his or her height (38). 
After a five-minute rest in the dentist’s examination chair in the examining room, data about 
systolic and diastolic BP and pulse were collected using a digital wrist device. PG was 
measured by means of a digital capillary blood sample, 3-3.5 μL, using a glucometer. 
Follow-up 
The same written health declaration used at the study start was repeated in 2011. The health 
declaration was sent to the patients by post along with written information about the study. 
The questionnaire was returned in a postage-paid envelope or was collected by telephone. In 
those cases where patients had died, permission was requested from relatives to examine the 
deceased’s pharmacological treatment and possible cause of death. 
Definitions of risk levels 
In the initial screening, the cut-off value for diastolic BP was set at 90 mm Hg or more, 
except for diabetics, in which case the value was set at 85 mm Hg or more, and generally 140 
mm Hg or more for systolic BP. Patients who exceeded normal plasma glucose and diastolic 
BP values were referred to medical care to have their values checked, possibly determine a 
diagnosis and initiate relevant treatment. The inclusion criteria for being a risk patient for HT 
was diastolic BP, but in the present paper we also chose to explore the health development 
among those who had a systolic BP above 140, 160 and 180. 
The cut-off values for PG in the initial screening were dependent on the patient’s most recent 
food intake. For patients who had eaten during the past two hours, the value for suspected 
pathological plasma glucose was set at 9.5 mmol/litre plasma and for those who not had eaten 
during the past two hours, the value was established at 8.0 mmol/ litre plasma. For those 
fasting for the past eight hours, the cut-off value was set at 7.0 mmol/litre plasma. 
Outcome measures 
In the follow-up, measures were: 
- number of study participants who had passed away during the seven-year period 
- insertion of antidiabetics or antihypertensives during the seven-year period 
- changes in weight and height to calculate BMI 
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Statistical analysis 
Statistical analyses were performed using the SPSS statistical software (Release 22.0.0 SPSS 
Inc., Chicago, IL). Potential changes in the study material were analysed using Student’s t-
test for dependent samples and the McNemar Test. Student’s t-test for independent samples 
and the Mann Whitney U test were used for comparisons between pharmacological treatment 
groups. Risk analyses were conducted using univariable logistic regression and results were 
expressed as odds ratios (OR) with 95% confidence intervals (CI). A p-value < 0.05 was 
considered to be statistically significant. 
Ethics Statement 
The study was approved by the Regional Ethical Review Board in Uppsala, Sweden, in 
accordance with the ethical standards and with the Helsinki Declaration of 1975. The 
participants received written information about the study, were not compensated for their 
time, and their participation was voluntary. 
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7 RESULTS 
7.1 STUDY I 
Background data 
Of the 207 consecutively invited patients, 170 were recruited at their recalls for regular yearly 
check-up visits. The dropout rate was 17.9%, with the main explanations for not participating 
“no special reason” or “have regular medical care contact”. Other common reasons were 
“long distance for any sampling” and “do not want to know about an undiagnosed illness”. 
Rare frequent reasons included “don’t want” and “have given lab-samples elsewhere”. 
The mean age was 63.95 years (SD 12.4) ranging from 40 to 88, with more women (94) than 
men (76) participating. Two patients (1.2%) were edentulous and 31 patients (18.2%) were 
overweight according to their BMI values. 
Plasma glucose and blood pressure 
Of the 170 participating patients, 39 were referred to a medical doctor due to high diastolic 
values and/or high plasma glucose levels at their screenings. Ten of these 39 patients 
exhibited plasma glucose values beyond the cut-off level, fasting glucose >7.0 millimoles per 
litre (mmol/l) or values in excess of levels adjusted to elapsed time since their last meals. 
Four of these ten required further care according to the medical physician conducting their 
examinations. The correlation between oral health care and medical care in recording plasma 
glucose was 40.0% (p<0.001). 
Thirty-one of the 39 who were referred exhibited diastolic BP beyond the cut-off level at the 
screenings. Twenty of these 31 patients who exceeded normal diastolic blood pressure 
required further care according to the examining medical physician. The correlation between 
oral health care and medical care in recording blood pressure was 64.5% (p<0.001). Three of 
these 20 also required further care caused by high plasma glucose, which demonstrates the 
close relation between high BP and high plasma glucose. We found systolic BP significant 
correlated to plasma glucose (p=0.005). 
  
 41 
 
Consequently, 24 (61.5%) out of the 39 referred patients required additional care (p<0.001).  
For further general and medical-related background data and periodontal status, please see 
Tables 7 and 8. Eighty-eight of the 170 patients had systolic BP beyond the cut-off level. 
Table 7. General and related medical background data 
 
Total 
N=170 (100 %) 
Middle-aged 
n=90 (52.9%) 
Elderly 
n=80 (47.1%) 
 Total 
Men/ 
Women 
Total 
Men/ 
Women 
Total 
Men/ 
Women 
Total 170 76/94 90 42/48 80 34/46 
% in group  44.7/55.3  46.7/53.3  42.5/57.5 
Mean BMI 26.3 26.6/26.1 27.0 27.8/26.3 25.6 25.1/25.9 
Overweight BMI 31 13/18 21 11/10 10 2/8 
% in group 18.2 17.1/19.1 23.3 26.2/20.8 12.5 5.9/17.4 
Smokers 23 10/13 19 8/11 4 2/2 
% in group 13.5 13.2/13.8 21.1 19.0/22.9 5.0 5.9/4.3 
Smoked 6 or more  
cigarettes/day 
17 6/11 16 6/10 1 0/1 
% in group 10.0 7.9/11.7 17.8 14.3/20.8 1.3 0/2.2 
Medication for CVD. 
anti- hypertension 
medication 
  
59 25/34 18 8/10 41 17/24 
% within group 34.7 32.9/36.2 20.0 19.0/20.8 51.3 50.0/52.2 
Medication for 
diabetes mellitus 
 
12 9/3 5 4/1 7 5/2 
% in group 7.1 11.8/3.2 5.6 9.5/2.1 8.8 14.7/4.3 
Mean pulse rate 69.3 69.1/69.4 70.2 70.9/69.6 68.3 67.0/69.2 
One individual medicated for low BP 
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Table 8. Periodontal status 
 
Clinical periodontal status 
Radiographic 
periodontal status 
Total 
dentated 
(Total x-
rayed)  
 
Number of 
pockets with 
depth ≥ 4 mm 
Mean pocket 
depth ≥ 4 mm 
Total mm of 
registered pocket 
depth ≥ 4 mm 
Marginal alveolar 
bone loss 
Quartiles q1 q2 q3 q1 q2 q3 q1 q2 q3 q1 q2 q3  
 
 
 
 
 
< 65 
years 
Men 
Count 9 15 18 8 19 15 8 21 13 17 21 3 42 (41) 
% in sex 21.4 37.5 42.9 19.0 45.2 35.7 19.0 50.0 31.0 41.5 51.2 7.3 100.0 
Women 
Count 16 13 19 16 19 13 16 18 14 13 26 7 48 (46) 
% in sex 33.3 27.1 39.6 33.3 39.6 27.1 33.3 37.5 29.2 28.3 56.5 15.2 100.0 
Total 
Count 25 28 37 24 38 28 24 39 27 30 47 10 90 (87) 
% in age 
group 
27.8 31.1 41.1 26.7 42.2 31.1 26.7 43.3 30.0 34.5 54.0 11.5 100.0 
 
 
 
 
 
> 65 
years 
Men 
Count 14 10 9 14 11 8 14 13 6 3 10 16 33 (29) 
% in sex 42.4 30.3 27.3 42.4 33.3 24.2 42.4 39.4 18.2 10.3 34.5 55.2 100.0 
Women 
Count 20 16 9 20 17 8 20 16 9 8 17 13 45 (38) 
% in sex 44.4 35.6 20.0 44.4 37.8 17.8 44.4 35.6 20.0 21.1 44.7 34.2 100.0 
Total 
Count 34 26 18 34 28 16 34 29 15 11 27 29 78 (67) 
% in age 
group 
43.6 33.3 23.1 43.6 35.9 20.5 43.6 37.2 19.2 16.4 40.3 43.3 100.0 
 
Clinical periodontal status and number of teeth 
The correlations between the number of pockets with depth of ≥ 4 mm, mean depth ≥ 4 mm 
and total mm pocket depth ≥ 4 mm were significant (p<0.001). These clinical periodontal 
status parameters are presented below as data of the number of pockets with depth of ≥ 4 mm. 
When all subjects had been analyzed, we found no significant correlations between the 
number of teeth or the clinical periodontal status and diastolic BP. Three out of four subjects 
with diastolic BP above the cut-off level (90 mm Hg; 85 mm Hg for patients with diagnosed 
DM) had pockets with a depth of > 4 mm, and 14 of the 31 subjects (45.2%) with diastolic 
BP above the cut-off level had > 3 pockets with a depth of > 4 mm. Please see Table 9 for 
correlations between blood pressure, plasma glucose (PG) and periodontal status. 
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Table 9. Correlation between blood pressure, plasma glucose and periodontal status 
 
Quartiles 
 
Diastolic 
BP 
< 90 (< 85) 
Diastolic 
BP 
> 90 (85) 
Systolic  
BP< 140 
Systolic  
BP > 140 
PG below 
cut-off level 
(non- DM 
medication) 
PG beyond 
cut-off level 
(non- DM 
medication) 
Number of teeth   < 20 teeth 48 9 20 37 54 (55) 3 (2) 
% in BP & PG group 34.5 29.0 24.4 42.0 33.8 (33.7) 30.0 (28.6) 
 > 20 teeth 91 22 62 51 106 (108) 7 (5)  
% in BP & PG group 65.5 71 75.6 58.0 66.3 (66.3) 70.0 (71.4) 
Number of pockets ≥ 4mm 
with PD of ≥ 4mm                      
q1 
 
51 8 27 32 54 (57) 5 (2) 
% in BP & PG group 37.2 25.8 32.9 37.2 34.2 (35.4) 50.0 (28.6) 
 q2 45 9 22 32 53 (53) 1 (1) 
% in BP & PG group 32.8 29.0 26.8 37.2 33.5 (32.9) 10.0 (14.3) 
 q3 41 14 33 22 51 (51) 4 (4) 
% in BP & PG group 29.9 45.2 40.2 25.6 32.3 (31.7) 40.0 (57.1) 
Mean pocket depth ≥ 4mm  q1 50 8 27 31 54 (56) 4 (2) 
% in BP & PG group 36.5 25.8 32.9 36.0 34.2 (34.8) 40.0 (28.6) 
 q2 55 11 31 35 63 (64) 3 (2) 
% in BP & PG group 40.1 35.5 37.8 40.7 39.9 (39.8) 30.0 (28.6) 
 q3 32 12 24 20 41 (41) 3 (3) 
% in BP & PG group 23.4 38.7 29.3 23.3 25.9 (25.5) 30.0 (42.9) 
Total mm of registered         
PD of ≥ 4 mm 
  q1 50 8 27 31 54 (56) 4 (2) 
% in BP & PG group 36.5 25.8 32.9 36.0 34.2 (34.8) 40.0 (28.6) 
 q2 54 14 29 39 65 (66) 3 (2) 
% in BP & PG group 39.4 45.2 35.4 45.3 41.1 (41.0) 30.0 (28.6) 
 q3 33 9 26 16 39 (39) 3 (3)  
% in BP & PG group 24.1 29.0 31.7 18.6 24.7 (24.2) 30.0 (42.9) 
Marginal alveolar bone 
loss 
q1 35 6 25 16 41 (41) 0 (0) 
% in BP & PG group 27.8 21.4 31.6 21.3 28.5 (27.9) 0 (0) 
 q2 62 12 42 32 69 (71) 5 (3) 
% in BP & PG group 49.2 42..9 53.2 42.7 47.9 (48.3) 50.0 (42.9) 
 q3 29 10 12 27 34 (35) 5 (4) 
% in BP & PG group 23.0 35.7 15.2 36.0 23.6 (23.8) 50.0 (57.1) 
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There were significant correlations between the number of teeth and systolic BP (p=0.015) as 
well as medication to alleviate CVD (p=0.005 and non-parametric correlation p<0.001), but 
no correlation was found between the number of teeth and clinical periodontal status. The 
correlation between plasma glucose and clinical periodontal status displayed no significance, 
but 57.1% of those subjects who exhibited plasma glucose above the cut-off level and who 
were not on medication for DM had > 3 pockets with a depth of ≥ 4 mm. 
Radiographic periodontal status 
In 16 cases (9.4%), it was not at all possible to measure the marginal alveolar bone loss on x-
ray owing to their being edentulous, having small dentitions or a total lack of reference points 
on x-rays: among middle-aged subjects 3.3% and among elderly subjects 16.3% fell into this 
category. The mean for missing data was 20.3% of the 154 cases under study; among middle-
aged subjects the mean was 10.8% and among elderly subjects, the mean for missing data 
was 32.8%. 
There was no significant correlation between plasma glucose and radiographic periodontal 
status, but all subjects who displayed plasma glucose above the cut-off level exhibited 
marginal alveolar bone loss > 2 mm, and 57.1% of the members of this group who were not 
on medications for DM had > 3.4 mm. 
One hundred thirteen of the 154 dental patients (73.4%) had radiographic marginal alveolar 
bone loss of > 2 mm according to the distribution in Table 3. The mean bone loss of middle-
aged subjects was 2.4 mm (SD 0.9) and in elderly subjects 3.2 mm (SD 1.2). 
In analyzing all patients, no significant correlations were discovered between marginal 
alveolar bone loss and diastolic BP. Four of five subjects with diastolic BP above the cut-off 
value showed marginal alveolar bone loss of > 2 mm. Of these 113 with > 2 mm, 22 (19.5%) 
had screened diastolic BP above the cut-off value, as compared with six patients (14.6%) of 
41 with a bone loss of < 2 mm. There was no correlation between marginal alveolar bone loss 
(p=0.07) and taking medication to alleviate CVD. 
However, there was both a significant correlation (p<0.001) and a significant non-parametric 
correlation (p=0.001) between systolic BP and marginal alveolar bone loss. Twenty-seven 
patients out of a group of 39 (69.2%) with a bone loss of > 3.4 mm showed systolic BP > 140 
mm Hg. The correlation was stronger for men (p=0.001) than for women (p=0.038) and there 
was also a significant non-parametric correlation (p=0.008 and p=0.049, respectively). 
Furthermore, significant correlations for middle-aged (p=0.039) and elderly (p=0.029) 
subjects were also discovered. After controlling for age and sex, significant correlations 
between systolic BP and marginal alveolar bone loss remained among middle-aged men 
(p=0.036), while no such correlations were found among women. 
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Among elderly women, there was a significant correlation between marginal alveolar bone 
loss and clinical periodontal status (p=0.014), while a bone loss of > 2 mm was less frequent 
among non-smokers than among smokers. 
Age 
An analysis of all patients showed significant correlations between age and medication for 
CVD (p<0.001), diastolic BP (p=0.009), systolic BP (p<0.001), marginal alveolar bone loss 
(p<0.001), missing radiographic data (p<0.001) and clinical periodontal status (p=0.002). 
There were significant correlations between age and clinical periodontal status among non-
smokers (p=0.016) and men (p=0.007), whereas no such correlations were discovered among 
smokers and women. 
 
7.2 STUDY II 
Of the 28 selected potential interviewees, 19 agreed to participate. The reasons for not 
participating were: three were “out of town”, three “forgot how the screening was conducted” 
and three did not reply. Two of the participants then failed to appear for the agreed interview: 
one had decided not to participate in the study and the other failed to appear for the interview 
and then could not be reached either by phone or letter. Seventeen patients were ultimately 
interviewed (Table 10). 
Table 10. Characteristics of study material. Values are number of participants if not 
otherwise stated. 
 
Study material 
Medical 
screening 
N (%) 
 
Interview 
n (%)   
Samples 207  28  
Dropouts 37  11  
Participants 170 (100) 17 (100) 
Men 76 (44.7) 9 (52.9) 
Women 94 (55.3) 8 (47.1) 
Mean age 63.95 66.05 
Referred for health care 40 (23.5) 7 (41.2) 
Required health care or lifestyle recommendations 23 (13.5) 4 (23.5) 
 
Meaning-bearing units were extracted from the texts, and codes, subcategories and categories 
were formed (Table 11). Figure 14 gives a visual presentation of the findings. The analysis 
revealed three categories made up of a number of subcategories. One theme permeated them 
all. Below, these results are presented in greater detail. 
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Table 11. Examples of meaning-bearing units, codes, subcategories and categories. 
Codes Subcategory Category 
Codes and subcategories describing the 
category “Positive attitude to screening but 
dental professionals need to have specific 
knowledge of medical screening” 
  
Positive view on screening 
Prevent potential noncommunicable diseases 
Insight into a possible link between general 
and oral health 
Positive attitude to screening Positive attitude to screening 
but dental professionals need 
to have specific knowledge 
of medical screening 
Equal sampling standard by health care as 
byand dental professionals 
Similar education and training 
Professional skills in medical 
screening 
 
Requires proper knowledge   
Prepared to pay the same for the service Willingness to pay  
Codes and subcategories describing the 
category “Dental care provides continuity but 
is not a neutral environment” 
  
Dental regularity and continuity 
Different doctors, usually the same dental 
professional 
Dental care provides continuity Dental care provides 
continuity but is not a 
neutral environment 
Reluctance to seek medical attention   
White coat hypertension  
Dental fear 
Risk of erroneously high blood 
pressure in the dental 
environment 
 
Codes and subcategories describing the 
category “Feedback about the medical 
screening results and desired cooperation 
between dental and health care services” 
  
Getting a response about their health 
 
Feedback about the medical 
screening results 
Feedback about the medical 
screening results and desired 
cooperation between dental 
and health care services 
The dental care service becomes a link Integrated dental and health care  
Referral to health care   
Collaboration or integration between dental 
and health care 
  
Dental professional cannot make a medical 
diagnosis 
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Figure 14. Patient experiences of medical screening performed by the dental care service, as 
described in three categories and one theme. 
 
Manifest Analysis 
Positive attitude to screening but dental professionals need to have specific knowledge of 
medical screening 
This category included the subcategories “positive attitude to screening”, “professional skills 
in medical screening” and “willingness to pay”. 
All interviewees had positive thoughts and opinions about undergoing medical screening at a 
dental clinic. Some also had some insight into a possible relationship between general health 
and oral health, which made them even more interested in a screening. 
It’s good that the dentist does a medical screening since there may be a relationship 
between the two. And I guess there’s something to the idea that teeth and things affect 
the rest of one’s body. If medical screening can prevent diseases and injuries in time, 
that’s definitely an advantage. 
The interviewees felt it was important for the dental care staff to have adequate knowledge if 
they were going to do medical screening, and also stated that there was no difference between 
dental and health care staff when it came to the practical performance of the screening. 
Actually, I thought they were just as professional as at the doctor’s office. I didn’t 
experience any difference. In my opinion, he has, I guess, as I see it, they are basically 
trained in similar ways. 
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The interviewees were willing to pay for this service. Since they paid at the health care 
service, they could just as well pay the same at the dental care service. 
I don’t mind paying, since I uh, go to the health center and then I have to go there. And 
pay for it. So uh, if the price is the same. 
Dental care provides continuity but is not a neutral environment  
This category included the subcategories “dental care provides continuity” and “risk of 
erroneously high blood pressure in the dental environment”. 
Many interviewees remarked that they go to their dentist yearly, and usually see the same 
dentist, so they go there more often than to the doctor, which made medical screening by the 
dental service seem convenient. 
You always see a different doctor, but usually the same dentist. I think lots of people go 
to the dentist more regularly than to the doctor. 
The advantages of dental regularity and continuity were stressed by several interviewees, who 
pointed out that some people are reluctant to seek medical attention. They neglect their 
symptoms. Dental care can help identify patients at risk with this screening. 
I go to the dentist more often than the doctor. So this is a good way for me to get 
checked, you might say. 
On the other hand, I would be glad to have it discovered in time because then I would 
actually be able to do something about it. 
Some of the interviewees mentioned that it was important for the dental services to consider 
source of error in blood pressure sampling. They pointed out an uncertainty in pressure 
measurement when they had a high value at the clinic but a normal value when their blood 
pressure was taken at home or after rest at the health center. Some interviewees could not 
remember any period of rest before their blood pressure was taken, but said that it was just 
the same as at the doctor’s office. 
When they take your blood pressure when you are there to see the dentist and are a 
little nervous, then it will be higher. That’s a natural reaction. In fact it always goes up 
when you are the dentist’s or the doctor’s office. It would go up a little bit in any case. 
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Feedback about the medical screening results and desired cooperation between dental and 
health care services 
This category included the subcategories “feedback about the medical screening result”, and 
“integrated dental and health care”. 
The interviewees emphasized the importance of getting a response about their health through 
feedback after the screening. They pointed out that if medical screening were included in the 
annual dental appointment, it would be important to receive feedback. 
Well, nothing happened afterwards. So I think that was one thing, getting no follow-up. 
I don’t know what happened. If I had had high blood glucose I don’t know if there 
would have been follow-up, either. 
It was not clear to everyone as to whether there was established collaboration between the 
dental and health care services. Therefore, many interviewees pointed out such collaboration 
needed to be established before medical screening in dental settings could be introduced, and 
they even suggested integration between dental and health care. 
I don’t really understand why there is a distinction between the health care and dental 
services. 
If plasma glucose and blood pressure are checked by the dental care services, this should 
certainly make things easier for the health care staff and if necessary, the dental care service 
can send a referral to health care so the patient gets a new health care contact. In other words, 
the dental care services become a link. The interviewees considered that close collaboration 
was especially beneficial when disease symptoms are neglected. 
Well, I think I’d get help faster with a referral. It would be sent to my doctor, like. 
Which would make things happen better than if I tried to work it out myself. 
I’d see it as a good thing if they sent a referral – directly… of course there may be 
people who… would rather themselves … make the contact but I don’t see … any 
disadvantage about it. 
Not all but most of the interviewees were aware that the dental care services cannot make a 
medical diagnosis. 
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Latent analysis 
Medical screening in dental settings implies responsibility, which requires effective 
cooperation between the dental and health care services 
The latent analysis revealed that introducing medical screening in a dental care setting is a 
responsibility that requires good collaboration between the dental and health care services. 
Some interviewees in this project felt that the collaboration was not completely clear to them. 
When the patient’s screening values exceeded thresholds for disease risk, these at-risk 
patients would have the opportunity, if the dental care service referred them to the health care 
service, to receive health care earlier without having to contact the health care service 
themselves. The referral would result in a smoother and easier handling of their cases. 
However, it was important to the interviewees to experience the procedure as being carried 
out properly and safely. 
Some interviewees pointed out a feeling of insecurity in the lack of feedback and information 
about their test results. Many felt that they were not informed whether they had elevated 
values. All interviewees requested clear feedback if a medical screening were to be 
introduced in the dental care. Others realized that they probably would have been notified if 
they were at risk of disease. 
When they did the diabetes test I thought, uh, well, if they found anything I do hope they 
would call and tell me. Yes, and that there has to be a link to the health centre or 
something. With the dentist. 
Finding out that you are at risk of disease or possibly already have a disease was not negative, 
according to the interviewees. They all felt it didn’t matter whether this information came 
from the dental or medical services. The most important thing was that they found out. All 
interviewees realized that medical screening could lead to early disease detection. 
There can’t be anything negative about finding out that you’re sick. 
The attitude of the interviewees to the dental care services taking responsibility for their 
general health was positive, and they pointed out benefits of undergoing medical screening at 
the dentist’s office. However, one person out of the seventeen felt that this was not the 
responsibility of the dental service. 
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7.3 STUDY III 
The quantitative data  
The quantitative data was analyzed descriptively. The answers on the eighteen items resulted 
in 46% (108) positive responses to medical screening in dental settings, 41% (95) negative 
responses and 13% (31) non-responses. 
The qualitative data 
Meaning-bearing units were extracted from the texts, and subcategories and categories were 
formed (Table 12). Figure 15 gives a visual presentation of the findings. The analysis 
revealed four categories made up of nine subcategories. One theme permeated them all. 
Below, these results are presented in greater detail with citations. 
Subcategory Category 
Dentistry as the preferable context to perform medical 
screening in the society 
A need for evidence-based medical screening in the 
society  
Medical screening ought to be established in the 
society 
Dental hygienists and dental nurses are the most 
relevant professions to perform medical screening 
Dentistry must have relevant competence to 
perform medical screening 
Dental care requires supplemented competence and 
national guidelines to perform medical screening 
 
Essential competence could preferably be obtained 
through postgraduate studies 
 
Medical screening requires a responsibility to inform 
and direct the patient but not to follow up general 
diseases 
Medical screening requires cooperation between 
dentistry and health care 
Medical screening initiates and improves the 
cooperation between dental and health care 
 
Equal costs for the patient wherever medical screening 
is performed 
Dentistry is not the only context where medical 
screening could be performed 
Optional to provide medical screening in dental 
settings  
 
 
Table 12. Summary of subcategories and categories  
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Figure 15. Graphical presentation of the descriptive content analysis, subcategories, 
categories and theme 
 
Manifest descriptive content analysis 
Medical screening ought to be established in the society 
Dentistry as the preferable context to perform medical screening in the society 
The majority of the participants pointed out the importance of medical screening as a 
community-promoting action. They argued that dental care should take that responsibility, 
due to the fact that dental care follows its patients more frequently on a regular basis in 
comparison with health care. 
Because we can see basically the entire healthy population fairly regularly in dental 
care, it can be an advantage to identify a number of illnesses that could take a while to 
diagnose. For these, it could be a great advantage if this were the case. 
Those who were more reluctant stressed the difficulties of making an overall assessment and 
identifying at-risk individuals. A lack of resources in dentistry, skills shortages and sources of 
error in procedural techniques were mentioned as stumbling blocks. Territorial thinking was 
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also highlighted as a possible problem. The predominant portion of participants, however, 
agreed that these problems could be overcome through increased competence. 
… it’s still health care that owns this issue. So it has to be done in very close 
collaboration with health care, so that there is a, um, big picture for the patient. 
A need for evidence-based medical screening in the society 
A minor portion of the participants answered that medical screening was needed in our 
society, but stressed the need for common guidelines concerning competence, skills and 
patient management. The lack of evidence was also the main reason for not looking upon 
medical screening as something valuable. A few participants considered the need not 
equivalent to the cost. 
Dentistry must have relevant competence to perform medical screening 
Dental hygienists and dental nurses are the most relevant professions to perform medical 
screening 
Most participants made the judgment that dental care has the personnel to implement medical 
screening. Dental hygienists or dental nurses were considered to be the most suitable 
personnel group for the performance of medical screening in dental settings. Medical 
screening can be a natural part of the hygienist’s health conversation with their patients. 
Some participants argued that there is already a shortage of capacity in dentistry and the 
possible introduction of medical screening means increased need for resources. 
I think that we can develop the skills of a category of personnel in dentistry to perform 
this. A dental hygienist can be responsible for this after further training. 
Dental care requires supplemented competence and national guidelines to perform medical 
screening 
The majority of the participants answered that there was insufficient expertise in dental care 
to perform medical screening and that competence needed to be supplemented. Other 
participants clarified their answer by saying that dental care was capable of performing the 
investigations but lacked the skills to interpret the test results. One association brought up the 
opinion that dental care did not need specific regulations to govern the conduct of medical 
screening. There are already regulations and national guidelines in place to regulate various 
types of screening, but not specific regulations and guidelines for medical screening in dental 
settings, which would be demanded. 
Yes, I think that you can probably always in these situations have some form of 
regulations and guidelines. I think that you should have these, because otherwise you 
can’t perform medical screening if it’s not regulated in some way. 
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Essential competence could preferably be obtained through postgraduate studies 
Most participants agreed that basic education for both dentists and dental hygienists already 
contained a lot and that there was no space for new topics; however the competence could be 
obtained through postgraduate studies. One of the participants felt that the practical part 
should be during dental hygienists’ undergraduate studies. Others advocated a combination of 
undergraduate and postgraduate studies. 
Competence could be increased in undergraduate studies, because all higher education 
should be adapted to potential future conditions. This knowledge could also be 
acquired in continuing education. 
Medical screening requires cooperation between dentistry and health care 
Medical screening requires a responsibility to inform and direct the patient but not to follow 
up general diseases 
The participants agreed that dental care had the mission to identify patients at risk and the 
responsibility to inform the patient about the screening results, whether they were at risk of a 
medical disease or not, while emphasizing that dental care is not able to make medical 
diagnoses of general diseases. Dental care has an obligation to follow up the patient to a 
certain extent. That is, possibly referring the patient or recommending her to seek health care, 
and the follow-up should rest with health care. A necessity for effective cooperation is 
professional communication, through referrals. 
Yes, following up on the patient is a must. You have to refer the patient for further 
treatment. This requires good collaboration with primary care. 
… this assumes that there is a good communication between dentistry and health care 
so that the patient can be referred or transferred over to health care… The 
responsibility for continued care must lie with health care! 
Medical screening initiates and improves the cooperation between dental and health care 
The overwhelming majority of the participants answered that cooperation between dental and 
health care would improve health-promotion measures not only for the patients but also for 
society. The cooperation provides opportunities for evaluation of the at-risk groups who need 
to be screened, cut-off levels and referral management, and clear guidelines for 
implementation and communication. Misjudgments of sample values may result in increased 
workload for health care, a risk that can be reduced or possibly eliminated by collaboration. 
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Yes, this would certainly mean a greater workload when patients are referred who are 
not sick. 
Yes, I would really like it if we could cooperate … there are only benefits to be gained 
by all of this, that’s for sure … 
Dentistry is not the only context where medical screening could be performed 
Equal costs for the patient wherever medical screening is performed 
Concerning costs, the participants responded very evenly. The participants said that it was a 
difficult question to talk about because the benefit of medical screening was not scientifically 
documented yet, as far as they were aware. But it was judged to be fair to the patient to pay 
the same amount regardless of whether dental or health care performed a screening. 
No, I think that the prerequisite for implementation of this is that there are no increased 
costs for the patient. 
Optional to provide medical screening in dental settings 
To the question of whether all dental settings should provide medical screening, just over half 
of the participants considered that there must be a care package that is optional and set by 
each individual dental clinic depending on the clinic’s interest. The remaining participants 
considered that all dental clinics should introduce medical screening. Introduction must be 
widespread to have a clear public health effect. The impact would not be as effective if 
medical screening did not reach out to the entire population. 
In a dream world, I would say of course, but I know that they won’t do it because not 
everyone is interested in this. 
Latent content analysis – theme 
Positive to, but uncertain about the concept of medical screening in dental settings 
Approached authorities and organizations generally had a positive view of medical screening 
in dental settings but the responding spokespersons were uncertain about the concept, because 
they experienced a lack of facts concerning the scientific knowledge position, guidelines and 
procedures in the topic (Figure 15). 
… it must be based on what existing scientific evidence there is for medical screening 
actually reducing disease in the population and contributing to overall health. In other 
words, it must be based on existing medical screening actually having a positive effect, 
and if it does, well then it is obvious there should be clear rules governing it … Just like 
all women of a certain age are offered mammograms! 
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7.4 STUDY IV 
Background data 
Of the included 170 participants (Figure 13), 151 (88.8%) finally participated in the seven-
year follow-up, a dropout of 11.2% (Figure 16). Six choose not to attend the follow-up and it 
was not possible to collect medical data from 13 of the 20 participants who had passed away. 
Six of these 20 patients were among those who were referred to healthcare in the initial 
screening (15.4% 6/39) and 14 were among the non-referred patients (10.7% 14/131). At the 
initial screening, the mean age was 63.95 years, range 40-88 years, and at the follow-up, the 
mean age was 69.12 years, range 47-94 years. 
 
Figure 16. Background data 
 
Hypertension 
Diagnosis and treatment 
Of the 170 participants in the initial screening, 39 were referred to medical care for suspected 
high BP or high PG, and 24 of these received pharmacological treatment. Two of these 39 
referred patients suffered from both high BP and high PG. The frequency of pharmacological 
treatment for high BP at the two data collection sessions is presented in Table 13. At follow-
up, there was a significant change in pharmacological treatment; 32 had changed their 
pharmacological treatment with antihypertensive drugs, of which 28 had started and four had 
ceased (p<0.001 McNemar Test). 
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Table 13. Pharmacological treatment for hypertension in 2004 and 2011, according to 
gender and age 
 Total N=170 
Pharmacological treatment 
for hypertension 
 
Medicating 
Not/quit 
medicating 
 
Missing 
Not referred 
2004 
Referred  
at risk 2004 
Pharmacological 
treatment 2004       
2004 Number of patients  59  111 0 139 31 20 
 Mean age (years) 69.5 61.0 0 64.6 61.1 62.0 
 Of which male (%) 43.4 45.9 0 39.6 67.7 55.0 
2011  Number of patients  76 75 19    
 Mean age* (years) 72.4 65.7 72.0    
 Of which male (%) 40.8 44.0 63.2    
 
Number of patients 
with changed 
treatment during the 
7-year period 
 
 
28 
 
 
4 
    
 Mean age* (years) 69.8 79.0     
 Of which male (%) 46.4 25.0     
 
Number of patients 
with new treatment 
during the 7-year 
period 
   
 
 
19 
 
 
9 
 
 Mean age* (years)    72.0 65.2  
 Of which male (%)    31.6 77.8  
*Alive 
 
Risk 
The future risk for treatment with antihypertensive drugs after seven years, estimated based 
on the diastolic and systolic BP registered at the initial screening, resulted in the following 
calculations of OR. The OR for medicating with antihypertensive drugs in 2011, for those not 
receiving pharmacological treatment at the initial screening in 2004, was 3.7 times greater for 
patients referred to have their screening values checked on the basis of diastolic BP than for 
those who not were referred (p=0.025; CI 1.2-11.3). 
Based on systolic BP, the OR for medicating with antihypertensive drugs in 2011, for those 
not receiving pharmacological treatment at the initial screening in 2004, was 3.9 times greater 
if they had a systolic BP of 140-159 mm Hg at the screening than for those who had a 
systolic BP <140 mm Hg (p=0.020; CI 1.2-12.6). 
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The OR for medicating with antihypertensive drugs in 2011, for those not receiving 
pharmacological treatment at the initial screening in 2004, was 54.2 times greater if they had 
a systolic BP >160 mm Hg at the screening than for those who had a systolic BP <140 mm 
Hg (p<0.0001; CI 9.8-300.3). 
Correlations among subgroups 
Among the referred group (n=31), nine out of those eleven (Table 1) who had not received 
pharmacological treatment in 2004 had started pharmacological treatment with 
antihypertensive drugs by the time of the follow-up (p=0.004 McNemar Test). 
Among the group of six who had a systolic BP >180 mm Hg and had not received 
antihypertensive drugs at the initial screening in 2004, one had passed away after seven years, 
one dropped out and the remaining four medicated with antihypertensive drugs. 
Among those who had a systolic BP of 140-159 mm Hg at initial screening, ten had changed 
their pharmacological treatment with antihypertensive drugs, nine had started and one had 
ceased (p=0.021 McNemar Test). For those who had a systolic BP of 160-179 mm Hg, nine 
had started using antihypertensive drugs (p=0.004 McNemar Test). Four who not medicated 
with antihypertensive drugs and had a systolic BP >180 mm Hg at initial screening medicated 
after seven years. 
Diabetes 
Diagnosis and treatment 
Ten of the 39 referred patients exhibited PG values beyond the cut-off level and four of them 
required further care according to the medical physician.22 Two suffered from both high BP 
and high PG. The frequency of pharmacological treatment for DM at the two data collection 
sessions is presented in Table 14. 
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Table 14. Pharmacological treatment for diabetes mellitus in 2004 and 2011, according to 
gender and age 
 Total N=170 
Pharmacological treatment 
for diabetes mellitus 
 
Medicating 
Not/quit 
medicating 
 
Missing 
Not referred 
2004 
Referred  
at risk 2004 
Pharmacological 
treatment 2004       
2004 Number of patients 12  158 0 160 10 4 
 Mean age (years) 66.8 63.7 0 63.5 70.5 74.8 
 Of which male (%) 75.0 42.4 0 43.8 60.0 50.0 
2011  Number of patients 16 134 20    
 Mean age* (years) 72.9 68.6 71.2    
 Of which male (%) 56.2 39.6 60.0    
 
Number of patients 
with changed 
treatment during the 
7-year period 
 
 
3 
 
 
1 
    
 Mean age* (years) 70.0 78     
 Of which male (%) 0 0     
 
Number of patients 
with new treatment 
during the 7-year 
period 
   
 
 
3 
 
 
0 
 
 Mean age* (years)    70.0 0  
 Of which male (%)    0 0  
*Alive 
 
Risk 
It was not possible to do risk calculations due to the limited group sizes. 
Correlations among subgroups 
Regarding pharmacological treatment for DM, three had started and one stopped. The 
changes in treatment were not significant (p=0.63 McNemar Test). 
Further analysis of the data did not show any significance. 
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Incidental finding – BMI 
An incidental finding was the not statistically significant developments of BMI. The original 
population and the diastolic-based referred group with subgroups had a mean increase of 
0.15-0.60 in BMI. Those who had a systolic BP of 140-159 mm Hg at the initial screening 
had a mean decrease in BMI of -0.24 (CI -0.87-0.39). Those who had a systolic BP of 160-
179 mm Hg had a mean increase in BMI of 0.25 (CI -0.39-0.89). However, those who had a 
systolic BP >180 mm Hg had a mean increase of BMI of 2.05 (CI -2.49-6.59), which is eight 
times greater average increase in BMI than those with a systolic BP of 160-179 mm Hg at the 
initial screening. 
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8 DISCUSSION 
8.1 IDENTIFYING PATIENTS AT RISK IN DENTAL SETTINGS 
Main findings 
We often found undiagnosed high BP and high plasma glucose values in our 170 subjects. 
Forty patients with high values were referred, with 23 of them requiring further care (13.5% 
of all participants). The correlation between oral health care and medical care in recording 
blood pressure was 64.5%, whereas the same correlation for plasma glucose was 60.0%. 
No significant correlations between plasma glucose and periodontal status were found. 
Among elderly subjects, there was a significant correlation between marginal alveolar bone 
loss and high systolic BP. 
High BP, a global problem, was noted in 26.4% of the adult population in 2000 (77), with 
ischaemic heart disease and cerebrovascular disease being the leading causes of death (78). In 
this study, we found that registered BP was correlated to radiographic marginal alveolar bone 
loss. Male subjects 40-65 years of age evidenced the strongest such correlation, as did 
subjects of both genders aged 65 and over. 
Incidental findings 
Periodontitis in the elderly is not easily confirmed as affected teeth may already have been 
extracted, because of a perceived need for removal or the previous more technical approach 
towards dentistry (79). In this study, we noticed incidentally that radiographic marginal 
alveolar bone loss was present more often than clinical periodontal status, such as BOP linked 
to pocket depth of ≥ 4 mm, probably thanks to the individualized prophylactic care programs 
used in the clinic concerned. A pocket depth of ≥ 4 mm may be a sign of active periodontal 
disease, while radiographic bone loss is a clear sign of previous periodontal disease. 
In the present study, we also incidentally observed that the number of surfaces on which it 
was impossible to measure marginal alveolar bone loss on x-rays was larger among the oldest 
patient group. Elderly tend to have a lot of dental restorations that complicate the 
measurement on bitewing x-rays owing to obscured CEJ (80). 
Contemporary Swedish elderly tend to increasingly keep their natural teeth (81). The 
importance of medical screening for oral health was highlighted in a study in which the 
authors concluded that the metabolic syndrome and presence of markers for inflammation, in 
addition to traditional risk factors for tooth loss, represented threats to maintaining natural 
teeth in elderly populations (82). Relevant current data also support the existence of a 
relationship between metabolic disturbances and periodontitis (83). 
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Strengths and limitations 
The strength of this investigation is that it was conducted at an ordinary public general dental 
practice by standard oral health professionals whose mission was to identify patients at risk of 
CVD and DM. Today, several wrist devices have been validated using the British 
Hypertension Society protocol; however, validated upper arm devices are still preferred over 
wrist devices  and should, therefore, be recommended for screening activities and control 
measurements (84). A digital automatic sphygmomanometer generates values algorithmically 
based on a single registration. Physiologically, the mean ambulatory monitored BP value is 
more realistic and has better prognostic value in making diagnostic assessments, but is less 
suitable in a screening situation (85). The results also show that although an ordinary 
glucometer made for monitoring concentrations of blood glucose at home was used, a 
correlation with medical health care of 60.0 % was achieved. A limitation of our study is that 
it was performed in one dental setting alone; other similar clinical research needs to be 
performed before the results may be considered transferable to all dental environments. 
Another limitation is that we made the assumption that patients would feel calm enough to 
achieve a relevant digital BP registration after a five-minute break. This was not the case, as 
88 of 170 patients (51.8 %) patients showed systolic BP above the cut-off value of 140 mm 
Hg. These results were probably attributable to “white coat hypertension”. Studies have 
shown that patients with high BP readings at a first appointment with a new physician show a 
mean fall of 15 ⁄ 7 mm Hg in systolic BP and diastolic BP by their third appointment. Some 
patients do not reach stable BP values until their sixth appointment (86, 87). Dental fear and 
phobia tend to complicate medical screening in dental settings, but the benefits of medical 
screening linked to the dental health system, with its annual recall program, may compensate 
for these disadvantages. 
Implications of this study 
Our findings indicate the possibility of identifying risk patients among men and elderly by 
examining radiographic marginal alveolar bone loss with the help of routine x-rays and by 
performing medical screenings by measuring BP. However, this requires the establishment of 
good routines for both the screening procedures and x-ray activities in dental settings. 
Another issue is whether dental professionals should be involved in the follow-up treatment 
of hypertension, or alternatively, merely collaborate closely with primary care services in 
identifying patients at risk. 
The absence of a significant correlation between plasma glucose and periodontal status in this 
study may be attributable to the limited population sample screened or the extended targeted 
periodontal prophylaxis received by patients with diabetes. 
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Syrjänen discovered that severe chronic dental infection in young and middle-aged men 
seems to be strongly associated with stroke (cerebral infarction), a finding that stresses the 
importance of giving men who evidence markers of periodontal disease extended periodontal 
prophylaxis (88). According to our study findings, this also seems relevant for elderly 
patients in the same situation. 
In the absence of a definitive causality, our level of knowledge does not yet enable us to call 
periodontal status a predictive factor for cardiovascular disease or diabetes mellitus. A 
statistical limitation also occurs when many statistical associations tested are omitted. In such 
instances, error rates may soar dramatically, thereby increasing the risk of reaching erroneous 
conclusions. However, the data of our study might be used to propose a description of 
cardiovascular parameters and plasma glucose concentrations in groups with affected 
periodontal status. Our findings suggest a need for additional studies with larger population 
samples. 
Among Swedes aged 50 and above, 81.6% of this population reported having seen a dentist 
within the preceding year in 2007 (89).  The continuity of providing ongoing dental services 
presents an opportunity to identify both oral and general risk factors and points out the benefit 
of medical screening in dental settings which is why such screening activity has recently been 
introduced to dentistry and is the subject of research because of its positive results (37, 59, 
90-98). 
 
8.2 PATIENT EXPERIENCES OF MEDICAL SCREENING PERFORMED BY 
THE DENTAL SERVICES 
In the present study, it was revealed that all interviewees had a generally positive attitude to 
undergoing medical screening as part of their regular dental examinations. Dentists’ 
attitudes to medical screening as a part of the dental examination have also been reported to 
be positive (94, 99). 
Method discussion 
It is important to achieve trustworthiness in a qualitative study (73). Both authors, Göran 
Friman and Inger Wårdh, have completed education in qualitative methodology and Inger 
Wårdh has experience from conducting several qualitative studies. To assure credibility, the 
interviewer in the present study was a person unknown to the participants and the 
interviews were conducted in a neutral venue not adjacent  to the dental clinic (73). 
There was a strategic selection of participants and the sampling continued until the authors 
concluded that no new information emerged, although there were very few negative 
comments from the interviewees. The dental clinic at which the screening was carried out 
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has individualized prophylactic care programs, and some interviewees may have been 
informed in that context about possible relationships between oral health and general 
health. All interviewees had previously agreed to undergo medical screening. These factors 
and the fact that some of the interviewees were referred to the health care services after the 
medical screening, where they were given further treatment and/or lifestyle 
recommendations, may have helped them to understand the benefits of the process of 
medical screening. It is possible that some of the individuals who declined to participate 
might have had a negative attitude about medical screening. Another choice of method, for 
example an anonymous postal questionnaire to all those who participated in the screening, 
might have been more effective at capturing negative attitudes (98). 
The researchers made their analyses as quickly as possible after the data collection to 
minimize the risk of changes in the researchers’ interpretations, to increase the 
dependability (73). After each interview, the interview process was evaluated to secure 
relevant data for the next interview. 
Accurate written description of the research process and the context was made to pursue 
transferability (73) and to give the reader the ability to evaluate whether these findings are 
transferable to other contexts. 
Result discussion 
All but one of the interviewees in this study was positive to the procedure with medical 
screening in dental settings and were willing to pay for this service. They appreciated the 
continuity the dental services provide and expressed some dissatisfaction with the absence 
of such continuity in Swedish health care. Similar positive results are revealed in qualitative 
studies of patients’ attitudes toward diabetes or HIV testing in dental settings (99, 100). A 
questionnaire study among adults with diabetes in Great Britain revealed that 53.5% of the 
participants supported dentists’ involvement in diabetes screening and that 20.9% would be 
willing to pay for diabetes screening in a dental setting (101). In the opinion of the authors, 
this relatively low interest in medical screening in Great Britain may be attributable to poor 
awareness of the importance of oral self-care and limited awareness of the oral health 
complications associated with diabetes. 
Our interviewees can be regarded as quite well informed about both oral and general health. 
They had formulated demands and expectations if medical screening were to be introduced 
in dental care and thought it was self-evident that a dentist has a responsibility to have 
adequate medical knowledge before undertaking such testing. Dentists have requested 
training and information about practical procedures if medical screening is introduced (94). 
Well-established cooperation with the health care services is equally important for optimal 
management of patients after screening. 
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It was especially pointed out by several of the interviewees as a major advantage that the 
dental service provides this contact in the form of a written referral in case of exceeded 
threshold values. This is the responsibility of the dental service, but dentists are not 
qualified to make medical diagnoses. The aim of medical screening performed by the dental 
care service is to identify patients at risk. 
As pointed out by the interviewees, this kind of screening could result in false positive 
results concerning high blood pressure because of “white coat syndrome” in a somewhat 
intimidating dental environment. This could lead to both unnecessary appointments, 
overloading the health care system, and unnecessary anxiety in some patients about their 
health status. However, studies from the US indicate that high blood pressure at the 
dentist’s office may have other, more relevant, causes and that such patients would benefit 
from further investigation (102). 
The interviewees pointed out the importance of feedback and knowledge of the results of 
the medical screening. Even those interviewees whose results did not exceed the threshold 
values for disease risk wanted to receive both oral and written information about their 
screening results. 
Medical screening in dental settings may help individuals with unknown high blood 
pressure and/or high plasma glucose levels to receive early medical help. This could also be 
seen in a broader perspective of public health, although the present results are only 
applicable in their own and possibly similar contexts. 
 
8.3 MEDICAL SCREENING IN DENTAL SETTINGS, VIEWS OF AUTHORITIES 
AND ORGANIZATIONS 
This study showed that the spokespersons were generally positive to medical screening in 
dental settings but requested more knowledge as they were uncertain about the concept. 
Method discussion 
The quantitative questionnaire data were analyzed descriptively by means of respondents’ 
positive and negative attitudes towards medical screening. The aim was to make the 
respondents take a position on medical screening. A limitation appeared at this stage, as 
several respondents avoided answering. But this weakness was turned into a strength in the 
subsequent collection of qualitative data during the interviews, where respondents were 
asked why they previously avoided taking a stand, which resulted in a more comprehensive 
answer. However, this study should not be considered a report from Swedish authorities 
and organizations concerning medical screening, as some presumptive respondents did not 
wish to participate. 
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Achieving credibility is always important in all research, especially qualitative methods 
(73). To ensure credibility, the interviewer was a person unknown to the respondents and 
who had limited pre-understanding of the subject (73). The respondents decided themselves 
where the interview should be conducted. Concerning the telephone interview alternative, 
there is a lack of additional information due to nonverbal reactions, but this was in some 
cases the only possibility of holding an interview, and a comparison of face-to-face and 
telephone interviews has revealed no significant differences in yielded results (103). 
A limitation of the study was that the participants responded as representatives of Swedish 
authorities and organizations but partly with personal opinions. As a spokesperson for an 
authority or organization, it can be presumed that the spokesperson provides substantially 
representative answers, as official policy documents are not available. Neither should this 
study be taken for a total representative report from Sweden. 
The transcriptions and analyses were made as quickly as possible after the qualitative data 
collection to optimize the interpretations and to secure relevant data in order to increase the 
dependability (73). Accurate written descriptions of the research process and the context 
were prepared in order to pursue transferability and to give the reader the ability to evaluate 
whether these findings are transferable to other similar Swedish or foreign contexts (73). 
When analyzing the collected data, a triangulation could be done to increase the reliability 
of the results through parallel analysis of the collected quantitative and qualitative data 
(104). 
Results discussion 
Medical screenings in dental settings are showing an increasing trend, and in a study 
involving 28 dental practices in the US and Sweden, the Dental Practice-Based Research 
Network found that a significant proportion of tested dental patients had abnormal blood 
glucose values (105). These results confirm the clinical relevance and specific challenge of 
investigating and describing the view of authorities and organizations in a Swedish context. 
To our knowledge no studies have been performed concerning this topic. 
General health checks are evaluated in the Cochrane review article by Krogsbøll et al (46), 
who aimed to quantify the benefits and harms of general health checks. The authors 
summarized with the words “general health checks in adults did not reduce morbidity or 
mortality”. This review article has been discussed in scientific literature and one weakness 
of the report is that most studies began in the 1960s and ‘70s. Diagnosis and treatment 
methods may have changed over time and the report excluded studies involving only 
elderly individuals over 65 years of age (106). All the reviewed studies also evaluated 
asymptomatic populations that were excluded for disease or risk factors. The authors 
suggested finally that future research should focus on, for example, screening for 
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cardiovascular risk factors, chronic obstructive pulmonary disease, diabetes, or kidney 
disease, which opens the door for major studies (46). 
By the early 2000s, it was already the trend in the US to make dental hygienists an integral 
part of the health care workforce (56). As prevention specialists, part of their job was 
considered to be detecting the presence of general diseases. But there were educational 
requirements for medical screening and they did not make medical diagnoses. 
The Swedish National Board of Health and Welfare in Sweden has emphasized the 
importance of primary preventive measures like medical screening (National Guidelines for 
Diabetes Care – summary, 2013, http://www.socialstyrelsen.se/nationalguidelines). “Health 
and medical care should carry out a screening of individuals who run an increased risk of 
developing diabetes type II, primarily in order to offer lifestyle changes.” These guidelines 
were not directed at dental care at this stage. 
The aim of medical screening performed by the dental care service is early identification of 
patients at increased risk of developing coronary heart disease and diabetes mellitus, yet 
unaware of their increased risk (107). The same authors also presented that dental settings 
could be a health promotion entry point into medical care for individuals not previously 
engaged with a primary care provider (107). The cooperation between dental and medical 
care has proven to be an effective way to discover unknown hypertension (38, 95). 
In their 2015 National Guidelines for Diabetes Care, the Swedish National Board of Health 
and Welfare recommended that health care refer to dental care individuals with diabetes 
with increased risk of impaired oral health or ongoing inflammatory disease of the tissues 
surrounding the teeth and dental implants. This cross-border communication is intended to 
result in decisions on treatment and preventive measures against caries, periodontitis and 
peri-implantitis. This guideline promotes an increased cooperation between dentistry and 
health care (108). 
During the interviews it emerged that medical screening could be performed in many 
contexts, but experience indicates that routine opportunistic screening is easier to 
implement and more reliable than other screening programs that cannot leverage the 
existing infrastructures and human resources of formal medical settings (109). Dental 
settings are therefore a natural choice of context alongside primary medical care. 
Dentistry today is increasing cooperation with medical care regarding the treatment of other 
diseases that might be associated with hypertension, such as obstructive sleep apnea 
syndrome, OSAS (110, 111). This further points to dentistry as a preferable context for 
medical screening. 
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Some of the respondents felt that an early diagnosis is always economically beneficial for 
society, but they had little knowledge of what savings could be achieved. The cost 
effectiveness of screening is important, and this effectiveness was studied in a Swedish 
population and found to depend on whether blood pressure screening was combined with 
blood glucose screening as compared to separate screening for the two disease entities 
(112). 
An estimation made in United States indicated that medical screenings for diabetes 
mellitus, hypertension, and hypercholesterolemia in dental settings could save the health 
care system $13.51-$32.72 per person screened over one year, depending on the referral 
flow from dental care to health care (113). The reported estimated socio-economic benefits 
in the article have been supported by others (114). 
Nearly all spokespersons for the authorities or organizations replied that they had a lack of 
knowledge on the topic but saw opportunities for individual and societal gains with medical 
screening in dental settings. 
This study shows that the expected impact and implications for clinicians and policy 
makers is to further enhance the implementation and intensify research on medical 
screening in dental settings. 
 
8.4 LONG-TERM FOLLOW-UP OF OPPORTUNISTIC MEDICAL SCREENING 
WITHIN DENTISTRY 
In this study, we found the distribution of risk, diagnosis and treatments for HT and DM after 
seven years among patients screened in a dental setting, to be considerable and not easily 
predictable among subgroups. 
Strengths and limitations 
The strengths of this study were that it was conducted at an ordinary general dental practice 
and that it was possible to conduct a seven-year follow-up with few dropouts, which in turn 
made it feasible to evaluate potential long-term effects of the medical screening. However, 
the study also has limitations. First, the registration of pharmacological treatments at the 
initial screening and in the present follow-up study was based on self-reported information, 
which can cause internal bias. Second, the number of participants was limited and taken from 
a limited context. There was hardly any tooth loss among the participants during the seven 
years, probably due to the study clinic’s individualized prophylactic treatment program. This 
could explain why the results revealed no significant associations between periodontitis, tooth 
loss and pharmacological treatment for high BP or DM, as a number of other studies have 
found (115, 116). 
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Hypertension 
Hypertension is an age-related, slow-developing and leading risk factor for premature death. 
The correlation with increased age was showed in the present study as the prevalence of HT 
treatment increased from 34.7% to 50.3% during the seven-year period. It can be compared 
with a study conducted in Stockholm, Sweden from 2001 to 2004, where the prevalence for 
HT was 74.9%, and 41.6% of the total study population medicated (12). In the MONICA 
study, the prevalence for HT was 71.9% and 44.9% of the total study-population used 
pharmacological treatment with antihypertensive drugs (13). 
Diabetes 
During the seven years, there was an increase in the prevalence of treatment of diabetes, from 
7.1% in 2004 to 10.7% in 2011. This could be compared to a 2015 estimation of 17-21% for 
the Swedish population aged 60-69 years, with data taken from IDF Diabetes Atlas Seventh 
Edition 2015 (7). The present study’s lower prevalence may be due to the participants’ 
socioeconomic status or local medical assessments. It is more similar to the previously 
mentioned Stockholm study, where the participants’ mean age was 74.0 years and the 
prevalence for diabetes was 9.5% (12). The MONICA study of a population aged 65–74 
years in Northern Sweden showed a prevalence of 12.0% for diabetes in 2009 (13). 
Number needed to screen 
At the initial screening, 31 out of the 39 referred participants were referred due to a diastolic 
BP beyond the cut-off level. Twenty of these required further care according to the examining 
medical physician. Twenty out of a total of 170 screened participants (11.8%) thus required 
further care (38). The number needed to screen in this context was 8.5, which is a result that 
is consistent with another Swedish study that reported a number needed to screen of 12 to 
detect an individual with undiagnosed high BP (117). The finding that systolic BP increased 
the odds of receiving pharmacological treatment raises the question about how to select 
patients for referral to medical care. 
Implications for medical screening delivery and context 
The finding that some patients had suboptimal BP monitoring from healthcare services has 
been demonstrated in other studies (12, 13), and leads to the question of whether dental care 
should be involved as part of a multidisciplinary team to support the follow-up of 
prescriptions from health care providers (118). Medical screening can be performed in many 
contexts, not just in dental settings. However, all such activities have to be carried out in 
cooperation with health care. Such collaboration is supported by a majority of primary care 
practitioners and is demanded by the patients (119, 120).  
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Debatable benefits of general health checks are evaluated in a review article from Cochrane, 
and the authors suggested that future research should focus on screening for cardiovascular 
risk factors, chronic obstructive pulmonary disease, diabetes, or kidney disease (46). In 
England, the NHS Health Check programme in adults aged 40–75 was introduced in 2009. 
The intention was early identification of these non-communicable diseases (48). In order to 
reach more citizens, partnering dental care with primary care is being considered in order to 
reach the goal of screening once every five years (121). The results from the present study 
suggest that patients identified as risk patients may be screened each year, while those in 
these age groups who at screening are found to be healthy, may be screened every other year. 
Further research is needed, however, to confirm these proposed screening intervals. 
8.5 GENERAL DISCUSSION 
In the first study, all participants were tested regardless of whether they already had a 
diagnosed hypertension and/or DM or not. However, the PG level in diabetes varies and 
therefore can be an unreliable measurement to take in to consideration (122).   
The four articles in this thesis describe how an opportunistic medical screening in a dental 
setting in 2004 identified one out of seven patients to be in need of medical care, and that the 
patients were positive to the screening. The authorities and organizations approached in the 
studies were generally positive, however their representatives were uncertain about the 
concept. The fourth follow-up study revealed that opportunistic medical screening in a dental 
setting can be positive for public health both in the short- and in the long-term and supported 
more integrated healthcare practices between dental care and healthcare.  
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9 SUMMARY AND CONCLUSIONS 
SUMMARY 
An opportunistic medical screening seems to identify at least one in ten with undiagnosed 
hypertension or incorrect pharmacological treatment, and risk patients referred by dentistry 
who are not considered to require further healthcare interventions may benefit from an annual 
screening. The results also emphasize the need for an increased cooperation between dentistry 
and health care. 
CONCLUSIONS 
Study I 
The correlation between oral health care and medical health care registrations based on blood 
pressure and plasma glucose indicates that it may be appropriate for dental professionals to 
perform opportunistic medical screening and refer risk patients to the medical care system 
before complications occur. In order to identify medical risk patients in dental settings on the 
basis of high blood pressure, a suggestion may be to examine middle-aged men and elderly 
patients of both sexes who exhibit radiographic markers for marginal alveolar bone loss. 
Study II 
The interviewees experienced the dental care service as providing continuity. They would 
like to have regular medical screening at their regular dental appointments to identify risks of 
cardiovascular diseases and diabetes. However, they expressed that it was important for the 
dental care staff to have the necessary medical knowledge. 
They also wanted good cooperation between the dental and health care services, with clear 
feedback to the patients about both positive and negative results and, when appropriate, 
referrals to the health care service. 
Study III 
Approached authorities and organizations generally had a positive view of medical screening 
in dental settings but were uncertain about the concept. Further scientific knowledge and 
guidelines concerning the topic are needed before it can be commonly introduced and 
additional research on implementation strategies and long-term follow-up of medical 
screening are needed. 
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Study IV 
An opportunistic medical screening in dental settings seems to identify at least one in ten with 
undiagnosed hypertension or incorrect medication. If a systolic BP >160 mm Hg forms the 
assessment basis, a larger number could be identified.  
This study implicates that risk patients referred by dental care who are not considered to 
require further healthcare interventions may benefit from an annual dental care screening. 
Our results also emphasize the need for a more integrated health care practice for 
opportunistic screening. 
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10 SWEDISH SUMMARY 
Bakgrund 
Hjärtkärlsjukdomar och diabetes mellitus typ 2 ökar. Ju tidigare patienten kommer i kontakt 
med sjukvården, desto större möjlighet till enklare åtgärder såsom livsstilsråd för att minska 
risken för framtida komplikationer. Vanligen uppsöks sjukvården först vid tydliga symtom. 
Tandvården tillämpar regelbundna revisioner och har ett förebyggande synsätt. Den kan 
utgöra en arena för medicinsk screening och identifiera personer i riskzonen för 
odiagnostiserat högt blodtryck eller diabetes. Sådan verksamhet ligger utanför den rent 
odontologiska även om aktuell forskning påvisar associationer mellan oral och allmän hälsa. 
Tandvården ställer dock inte medicinska diagnoser. 
Screening anses både vara kostnadseffektivt och kunna ge folkhälsovinster. Men hur ska den 
utföras på bästa sätt? Samarbetet med sjukvården har poängterats, men det finns inget 
regelverk att luta sig mot. Ska alla patienter erbjudas medicinsk screening eller endast vissa 
grupper och hur ska en god återkoppling av screeningresultatet ges? 
Det övergripande syftet med avhandlingen var att undersöka möjligheter att hitta individer i 
riskzonen för odiagnostiserade sjukdomar och till ett samarbete kring detta mellan tandvården 
och sjukvården. 
De inledande målen var att identifiera tandvårdspatienter med risk att ha eller utveckla högt 
blodtryck eller hög halt plasmaglukos, undersöka möjliga samband mellan dessa tillstånd och 
munhälsan samt att utforska överensstämmelsen mellan tandvårdens och sjukvårdens 
registreringar. 
Patienternas upplevelser samt myndigheters och organisationers syn studerades i en andra 
och tredje studie. Efter sju år analyserades hälsoutvecklingen och medicineringen beträffande 
högt blodtryck och diabetes bland dem som deltog i den initiala medicinska screeningen i en 
fjärde och sista studie. 
Material och metod 
Totalt 170 tandvårdspatienter inkluderades konsekutivt vid en årlig revisionsundersökning. 
Uppgifter om ålder, vikt, längd, mängd och användning av tobak och läkemedel för 
hjärtkärlsjukdom och diabetes samlades in med en hälsodeklaration samt data om systoliskt 
och diastoliskt blodtryck och plasmaglukos. Klinisk och röntgenologisk undersökning gav 
uppgifter om parodontalt status genom ficksondering och genom att mäta marginal alveolär 
benförlust med hjälp av röntgen. Patienter som överskred normalvärden för diastoliskt 
blodtryck och plasmaglukos remitterades till sjukvården för eventuell diagnos och behandling 
(Studie I). 
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Med ett strategiskt urval av patienter, myndigheter och organisationer intervjuades 17 
patienter och 13 talespersoner. Intervjuerna spelades in och transkriberades. 
Transkriptionerna kodades och kategoriserades i en manifest analys, följt av en latent, 
tolkande analys (Studie II & III). 
De 170 deltagare som ingick i den inledande screeningen tillfrågades sedan om att delta i en 
uppföljningsstudie efter sju år. Data samlades in genom en upprepning av hälsodeklarationen 
(Studie IV). 
Resultat 
Trettionio av samtliga 170 deltagare uppvisade höga värden vid screeningen och 
remitterades. Av dessa 39 patienter, var 24 (14,1 %), en av sju screenade, i behov av 
sjukvårdsinsats. Korrelationen mellan tandvårdens registreringar och sjukvårdens beträffande 
blodtryck var 64,5 % (p<0,001), medan korrelationen beträffande plasmaglukos var 40,0 % 
(p<0,001). Bland medelålders män och äldre, fanns en signifikant korrelation mellan 
marginal alveolär benförlust och högt systoliskt blodtryck (p<0,001) (Studie I). 
Den manifesta analysen, det som direkt uttrycktes i transkriptionerna av patienternas 
upplevelser, resulterade i tre kategorier: Positiv attityd till screening, men tandvården behöver 
kunskap om medicinsk screening; Tandvården står för kontinuitet, men är inte en neutral 
miljö; Feedback på den medicinska screeningens resultat och önskan om samarbete mellan 
tandvården och sjukvården (Studie II). 
Den manifesta analysen av talespersonernas syn vid de utsedda myndigheterna och 
organisationerna, resulterade i fyra kategorier: Medicinsk screening bör etableras i samhället; 
Tandvården måste ha relevant kompetens för att utföra medicinsk screening; Tandvården är 
inte den enda kontext där medicinsk screening kan utföras; Medicinsk screening kräver 
samarbete mellan tandvården och sjukvården (Studie III). 
Den latenta, tolkande analysen av patienternas upplevelser påvisade krav på att 
registreringarna genomfördes korrekt och säkert, samt att de önskade tydlig feedback om 
screeningens resultat. De intervjuade talespersonerna såg positivt på medicinsk screening, 
men upplevde brist på evidens inom ämnet samt riktlinjer för genomförandet. De var osäkra 
på konceptet (Studie II & III). 
I den uppföljande fjärde studien deltog 151 av de ursprungliga deltagarna. Med det insamlade 
materialet och data från den första studien analyserades hur stor risken (Odds Ratio) var att 
2011 ha utvecklat behov av blodtryckssänkande läkemedel efter sju år, för dem som inte fick 
det vid den inledande screeningen 2004. 
För dem som inte fick läkemedel 2004, var risken 3,7 gånger större för dem som remitterades 
för att få sina screening-värden kontrollerade på grundval av diastoliskt blodtryck än för dem 
som inte remitterades (p=0,025; CI 1,2–11,3). 
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För dem som inte fick läkemedel 2004 och registrerades med ett systoliskt blodtryck 140–159 
mm Hg, var risken 3,9 gånger större än för dem med ett systoliskt blodtryck <140 mm Hg 
(p=0,020; CI 1,2–12,6). För dem med ett systoliskt blodtryck >160 mm Hg, var risken 54,2 
gånger större att ha utvecklat behov av blodtryckssänkande läkemedel efter sju år, än för dem 
med ett initialt systoliskt blodtryck <140 mm Hg (p<0,0001; CI 9,8–300,3) (Studie IV). 
Beträffande läkemedelsbehandlad diabetes, var det inte möjligt att göra riskberäkningar på 
grund av de begränsade gruppstorlekarna. Förändringarna var inte signifikanta. 
Konklusion 
Korrelationen mellan tandvårdens och sjukvårdens registreringar indikerar att det kan vara 
lämpligt att tandvården utför opportunistisk medicinsk screening då det kan gagna folkhälsan. 
Patienter och talespersoner för myndigheter och organisationer ställer sig i huvudsak positiva 
till en sådan verksamhet. 
En opportunistisk medicinsk screening tycks kunna identifiera en individ med odiagnostiserat 
högt blodtryck eller med okontrollerad medicinering av tio undersökta. De som remitteras av 
tandvården, men som av sjukvården inte anses kräva ytterligare hälso-och sjukvårdsinsats, 
tycks ha nytta av årlig screening.  Resultaten betonar också behovet av ett ökat samarbete 
mellan tandvården och sjukvården. 
Ytterligare kunskap krävs innan opportunistisk medicinsk screening inom tandvården mer 
allmänt kan introduceras, likaså behövs forskning om strategier för implementering och 
långtidsuppföljande studier för att säkerställa effekterna.   
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